Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease.
paper
Cited
Public
Unavailable
- Authors
- Kivipelto, Miia; Ngandu, Tiia; Fratiglioni, Laura; Viitanen, Matti; KΓ₯reholt, Ingemar; Winblad, Bengt; Helkala, Eeva-Liisa; Tuomilehto, Jaakko; Soininen, Hilkka; Nissinen, Aulikki
- Year
- 2005
- Journal
- Archives of neurology
- PMID
- 16216938
- DOI
- 10.1001/archneur.62.10.1556
BACKGROUND: Vascular risk factors play a role in the development of dementia, including Alzheimer disease (AD). However, little is known about the effect of body mass index and clustering of vascular risk factors on the development of dementia. OBJECTIVE: To investigate the relation between midlife body mass index and clustering of vascular risk factors and subsequent dementia and AD. DESIGN AND SETTING: Participants of the Cardiovascular Risk Factors, Aging, and Dementia (CAIDE) study were derived from random, population-based samples previously studied in a survey carried out in 1972, 1977, 1982, or 1987. After an average follow-up of 21 years, 1449 individuals (73%) aged 65 to 79 years participated in the reexamination in 1998. MAIN OUTCOME MEASURES: Dementia and AD. RESULTS: Obesity at midlife (body mass index>30 kg/m2) was associated with the risk of dementia and AD even after adjusting for sociodemographic variables (odds ratio [OR], 2.4 [95% confidence interval (CI), 1.2-5.1]). The association was somewhat modified by further adjusting for midlife blood pressure, total cholesterol level, and smoking (OR, 2.1 [95% CI, 1.0-4.6]) and also for apolipoprotein E genotype and history of vascular disorders (OR, 1.9 [95% CI, 0.8-4.6]). Midlife obesity, high total cholesterol level, and high systolic blood pressure were all significant risk factors for dementia with ORs of around 2 for each factor, and they increased the risk additively (OR, 6.2 for the combination). CONCLUSIONS: Obesity at midlife is associated with an increased risk of dementia and AD later in life. Clustering of vascular risk factors increases the risk in an additive manner. The role of weight reduction for the prevention of dementia needs to be further investigated.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Obesity, smoking, and frontal brain dysfunction. | 2010 | 20716301 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Association between unhealthy lifestyles and young-onset dementia: a nationwide cohort study. | Choi S et al. | β | 2026 | β |
| Bioenergetics and lipid metabolism in Alzheimer's disease: From cell biology to systemic health. | Maioli S et al. | β | 2026 | β |
| Brain lipid profiles and oligodendrocyte gene expression show discordant responses to high-fat diet in Alzheimer's disease mice. | Kawade N et al. | β | 2026 | β |
| Distinct metabolic signatures of Alzheimer's and Parkinson's disease revealed through genetic overlap. | Stinson SE et al. | β | 2026 | β |
| Obesity, cardiometabolic health status, and brain health in community-dwelling older adults. | Alphin KH et al. | β | 2026 | β |
| Oligodendrocyte dysfunction in alzheimer's disease: Integrating spatial epigenomics and metabolic circuitry in demyelination - A critical review. | Jian L et al. | β | 2026 | β |
| Prevalence of Alzheimer's disease pathology in the community. | Aarsland D et al. | β | 2026 | β |
| Weight loss and physical activity after total knee replacement: Study protocol for the Healthy Living randomized controlled trial. | Pellegrini CA et al. | β | 2026 | β |
| A 20-week, randomized controlled trial to determine the efficacy of the Aging Well through Interaction and Scientific Education - Action Plan (AgeWISE-AP) program in older Veterans. | O'Connor MK et al. | β | 2025 | β |
| Adiposity and dementia among Chinese adults: longitudinal study in the China Health and Retirement Longitudinal Study (CHARLS). | Zeng M et al. | β | 2025 | β |
| Alzheimer Disease, Vascular Disease, and Blood-Brain Barrier Permeability Biomarkers in Middle-Aged Adults. | Edwards NC et al. | β | 2025 | β |
| Bariatric Surgery Is Associated With Reduced Incidence of Mild Cognitive Impairment and Alzheimer Disease and Related Dementias: A Retrospective Cohort Study. | Chen Y et al. | β | 2025 | β |
| Dietary EPA and DHA enrichment of a high fat diet during doxorubicin-based chemotherapy attenuated neuroinflammatory gene expression in the brain of C57bl/6 ovariectomized mice. | Ormiston K et al. | β | 2025 | β |
| Effects of exercise training on cognitive function in community-dwelling older women. | Wang HY et al. | β | 2025 | β |
| Estimating global prevalence of mild cognitive impairment and dementia in elderly with overweight, obesity, and central obesity: A systematic review and meta-analysis. | Wei J et al. | β | 2025 | β |
| Evaluating Genomic and Clinical Risk Factors for Alzheimer's Disease in Individuals with Hypertension. | Kim E et al. | β | 2025 | β |
| Exploring the global impact of obesity and diet on dementia burden: the role of national policies and sex differences. | Cao X et al. | β | 2025 | β |
| Incretin-based therapeutics for the treatment of neurodegenerative diseases. | Vear A et al. | β | 2025 | β |
| Is late-life vulnerability to cardiovascular disease risk associated with longitudinal tau accumulation in older adults with mild cognitive impairment? | Dratva MA et al. | β | 2025 | β |
| Leptin, adiponectin, body mass index, and incident cognitive impairment. | Thacker EL et al. | β | 2025 | β |
| Machine learning-based estimation of the mild cognitive impairment stage using multimodal physical and behavioral measures. | Park I et al. | β | 2025 | β |
| Neuroinflammatory mechanisms linking high-fat diets to Alzheimer's disease vulnerability: Beyond the amyloid hypothesis. | Mackey-Alfonso SE et al. | β | 2025 | β |
| Physical Activity Moderates the Relationship between Cardiovascular Disease Risk Burden and Cognition in Older Adults. | Nguyen ST et al. | β | 2025 | β |
| Predicting Cognitive Outcome Through Nutrition and Health Markers Using Supervised Machine Learning. | Verma S et al. | β | 2025 | β |
| Predicting mortality risk in Alzheimer's disease using machine learning based on lifestyle and physical activity. | Tang R et al. | β | 2025 | β |
| Sex-dependent effects of a high-fat diet-induced obesity model on cerebrovascular health and brain metabolism. | Eminhizer NN et al. | β | 2025 | β |
| Shellfish-based dietary patterns and cognition in the Chinese senior population: A cross-sectional study in Qingdao, China. | Zhang J et al. | β | 2025 | β |
| The brain-joint axis: links between osteoarthritis and neurodegenerative disorders in aging. | Rabie MA et al. | β | 2025 | β |
| The Contribution of the Renin-Angiotensin System to Alzheimer's Disease. | GΓΌzel Γ et al. | β | 2025 | β |
| The effect of milk fat globule membrane phospholipid supplementation on cognitive function in older adults with subjective memory complaints-a randomized, double-blind, placebo-controlled trial. | Zajac IT et al. | β | 2025 | β |
| The pathophysiology of mixed Alzheimer's disease and vascular dementia. | Sarhan M et al. | β | 2025 | β |
| The role of the endocannabinoid system in managing neuropsychiatric symptoms in Alzheimer's disease. | Rao JS et al. | β | 2025 | β |
| Thyroid function and cognitive health: rethinking the relationship between "suboptimal" TSH/FT4 levels and cognitive decline. | Dori D et al. | β | 2025 | β |
| Using machine learning to identify risk factors for Alzheimer's disease among older adults in the United States: The role of chronic and behavioral health. | Ahmmad MR et al. | β | 2025 | β |
| Vascular models of Alzheimer's disease: An overview of recent in vitro models of the blood-brain barrier. | Takeuchi LE et al. | β | 2025 | β |
| Abdominal fat depots are related to lower cognitive functioning and brain volumes in middle-aged males at high Alzheimer's risk. | Golan Shekhtman S et al. | β | 2024 | β |
| A Brief History of the Progress in Our Understanding of Genetics and Lifestyle, Especially Diet, in the Risk of Alzheimer's Disease. | Grant WB | β | 2024 | β |
| Adipose tissue as a therapeutic target for vascular damage in Alzheimer's disease. | Bettinetti-Luque M et al. | β | 2024 | β |
| Advancing Alzheimer's Disease Modelling by Developing a Refined Biomimetic Brain Microenvironment for Facilitating High-Throughput Screening of Pharmacological Treatment Strategies. | Mohd Murshid N et al. | β | 2024 | β |
| Age at diagnosis of diabetes, obesity, and the risk of dementia among adult patients with type 2 diabetes. | Qi X et al. | β | 2024 | β |
| Alzheimer's disease: a comprehensive review of epidemiology, risk factors, symptoms diagnosis, management, caregiving, advanced treatments and associated challenges. | Safiri S et al. | β | 2024 | β |
| Alzheimer's Disease: Exploring the Landscape of Cognitive Decline. | Tenchov R et al. | β | 2024 | β |
| Association of body-mass index with physiological brain pulsations across adulthood - a fast fMRI study. | Raitamaa L et al. | β | 2024 | β |
| Association of genetically predicted 486 blood metabolites on the risk of Alzheimer's disease: a Mendelian randomization study. | Yang Q et al. | β | 2024 | β |
| Association of Hyperlipidemia and Hyperglycemia With Cognitive Function in Type 2 Diabetes: A Cross-Sectional Analysis. | Ansari T et al. | β | 2024 | β |
| Associations between sex, body mass index and the individual microglial response in Alzheimer's disease. | Biechele G et al. | β | 2024 | β |
| Circulating adipokines and MRI markers of brain aging in middle-aged adults from the community. | Satizabal CL et al. | β | 2024 | β |
| Cognition in patients with post-bariatric hypoglycemia. | Puleio A et al. | β | 2024 | β |
| Cognitive Decline in Ageing and Disease: Risk factors, Genetics and Treatments. | Colita E et al. | β | 2024 | β |
| Cross-sectional association between high-sensitivity C-reactive protein and cognitive function in community-dwelling older adults: the SONIC study. | Hosokawa M et al. | β | 2024 | β |
| Cross-talk between adipose tissue and microbiota-gut-brain-axis in brain development and neurological disorder. | Thakur P et al. | β | 2024 | β |
| Deep learning-based BMI inference from structural brain MRI reflects brain alterations following lifestyle intervention. | Finkelstein O et al. | β | 2024 | β |
| Dementia and metabolic syndrome: a bibliometric analysis. | Peng T et al. | β | 2024 | β |
| Dietary approach to stop hypertension (DASH), but not Mediterranean and MIND, dietary pattern protects against Parkinson's disease. | Keramati M et al. | β | 2024 | β |
| Differential effects of cholesterol levels on cognition according to body mass index in Parkinson's disease. | Jeong SH et al. | β | 2024 | β |
| Dynamic relations between longitudinal morphological, behavioral, and emotional indicators and cognitive impairment: evidence from the Chinese Longitudinal Healthy Longevity Survey. | Sun J et al. | β | 2024 | β |
| Experimental laboratory models as tools for understanding modifiable dementia risk. | Sinclair D et al. | β | 2024 | β |
| Exploring the Significance of Microglial Phenotypes and Morphological Diversity in Neuroinflammation and Neurodegenerative Diseases: From Mechanisms to Potential Therapeutic Targets. | Anwar MM et al. | β | 2024 | β |
| Heterogeneous treatment effects of sodium-glucose cotransporter 2 inhibitors on risk of dementia in people with type 2 diabetes: A population-based cohort study. | Tang H et al. | β | 2024 | β |
| High caloric intake improves neuronal metabolism and functional hyperemia in a rat model of early AD pathology. | Almanza DLV et al. | β | 2024 | β |
| Importance of serum albumin in machine learning-based prediction of cognitive function in the elderly using a basic blood test. | Karako K et al. | β | 2024 | β |
| Investigating the association between a history of depression and biomarkers of Alzheimer's disease, cerebrovascular disease, and neurodegeneration in patients with dementia. | Salwierz P et al. | β | 2024 | β |
| Leptin bioavailability and markers of brain atrophy and vascular injury in the middle age. | Charisis S et al. | β | 2024 | β |
| Longitudinal Impacts of Precision Greenness on Alzheimer's Disease. | Brown SC et al. | β | 2024 | β |
| Longitudinal trajectories of Alzheimer's disease CSF biomarkers and blood pressure in cognitively healthy subjects. | Biskaduros A et al. | β | 2024 | β |
| Molecular Mechanisms Linking Osteoarthritis and Alzheimer's Disease: Shared Pathways, Mechanisms and Breakthrough Prospects. | Umoh IO et al. | β | 2024 | β |
| Monoclonal antibodies and aptamers: The future therapeutics for Alzheimer's disease. | Barrera-Ocampo A | β | 2024 | β |
| Nitric oxide donors rescue metabolic and mitochondrial dysfunction in obese Alzheimer's model. | Allerton TD et al. | β | 2024 | β |
| Novel insights into brain lipid metabolism in Alzheimer's disease: Oligodendrocytes and white matter abnormalities. | Kawade N et al. | β | 2024 | β |
| Obesity affects brain cortex gene expression in an APOE genotype and sex dependent manner. | Pandit H et al. | β | 2024 | β |
| OM-85 attenuates high-fat diet-induced obesity, insulin resistance, gut dysbiosis and nonalcoholic steatohepatitis in a murine model. | Hewady S et al. | β | 2024 | β |
| Physical activity and mortality in patients with dementia: 2009-2015 National Health Insurance Sharing Service data. | Nam S et al. | β | 2024 | β |
| Regional covariance of white matter hyperintensity volume patterns associated with hippocampal volume in healthy aging. | Van Etten EJ et al. | β | 2024 | β |
| Relationship of Body Composition With Middle Cerebral Artery Hemodynamic Using Compositional Data Analysis in Middle-Age Adults From Toledo Study for Healthy Aging. | MuΓ±oz-MuΓ±oz M et al. | β | 2024 | β |
| Sex-Specific Association of Body Mass Index with Hippocampal Subfield Volume and Cognitive Function in Non-Demented Chinese Older Adults. | Lin S et al. | β | 2024 | β |
| Socioeconomic and medical determinants of state-level subjective cognitive decline in the United States. | de Havenon A et al. | β | 2024 | β |
| Standard and New Echocardio Techniques, Such as Global Longitudinal Strain, to Monitor the Impact of Diets on Cardiovascular Diseases and Heart Function. | Sartorio A et al. | β | 2024 | β |
| Super-Resolution Ultrasound Reveals Cerebrovascular Impairment in a Mouse Model of Alzheimer's Disease. | Lowerison MR et al. | β | 2024 | β |
| Systemic Modulators: Potential Mechanism for the 5-HT System to Mediate Exercise Amelioration in Alzheimer's Disease. | Wu Q et al. | β | 2024 | β |
| The Association between cognitive impairment and anthropometric indices among the elderly: birjand longitudinal aging study. | Ramezani Kashal F et al. | β | 2024 | β |
| The Association between Exposure to Fine Particulate Matter and MRI-Assessed Locus Coeruleus Integrity in the Vietnam Era Twin Study of Aging (VETSA). | Puckett OK et al. | β | 2024 | β |
| The Association Between Neuropathological Lesions and Body Mass Index Is Independent of Cognitive Abilities. | Ururahy RDR et al. | β | 2024 | β |
| The association between serum cholesterol levels and mild-to-moderate cognitive impairment in the Suita Study and evidence from other epidemiological studies. | Arafa A et al. | β | 2024 | β |
| The circadian syndrome is a predictor for cognition impairment in middle-aged adults: Comparison with the metabolic syndrome. | Shi Z et al. | β | 2024 | β |
| The role of cardiovascular health and vascular events in the relationship between excessive daytime sleepiness and dementia risk. | CavaillΓ¨s C et al. | β | 2024 | β |
| Tocotrienols Prevent the Decline of Learning Ability in High-Fat, High-Sucrose Diet-Fed C57BL/6 Mice. | Kato Y et al. | β | 2024 | β |
| Adiposity in the older population and the risk of dementia: The Rotterdam Study. | Mooldijk SS et al. | β | 2023 | β |
| A randomized controlled trial examining the effects of behavioral weight loss treatment on hippocampal volume and neurocognition. | Chao AM et al. | β | 2023 | β |
| Area-Level Infant Mortality Exposure in Early Life and Alzheimer's Disease Mortality: Examining Variation Based on Age, Sex, and Place of Birth. | Topping M et al. | β | 2023 | β |
| Autonomic nervous system and cardiac neuro-signaling pathway modulation in cardiovascular disorders and Alzheimer's disease. | Elia A et al. | β | 2023 | β |
| BMI decline patterns and relation to dementia risk across four decades of follow-up in the Framingham Study. | Li J et al. | β | 2023 | β |
| Cardiovascular Risk Factors and Risk of Alzheimer Disease and Mortality: A Latent Class Approach. | Ruthirakuhan M et al. | β | 2023 | β |
| Cholinesterase inhibitors associated with lower rate of mortality in dementia patients with heart failure: a nationwide propensity weighting study. | Hsieh MJ et al. | β | 2023 | β |
| Evaluation of Microvascular Rarefaction in Vascular Cognitive Impairment and Heart Failure (CRUCIAL): Study Protocol for an Observational Study. | van Dinther M et al. | β | 2023 | β |
| Evidence against a temporal association between cerebrovascular disease and Alzheimer's disease imaging biomarkers. | Cogswell PM et al. | β | 2023 | β |
| Exogenous exposures shape genetic predisposition to lipids, Alzheimer's, and coronary heart disease in the MLXIPL gene locus. | Loika Y et al. | β | 2023 | β |
| Exome-Wide Association Study Identified Clusters of Pleiotropic Genetic Associations with Alzheimer's Disease and Thirteen Cardiovascular Traits. | Loika Y et al. | β | 2023 | β |
| Feasibility of Internet-Based Physical-Cognitive Exercise for Health Benefits of Middle-Aged Obese Women. | Keawtep P et al. | β | 2023 | β |
| Fingolimod Modulates the Gene Expression of Proteins Engaged in Inflammation and Amyloid-Beta Metabolism and Improves Exploratory and Anxiety-Like Behavior in Obese Mice. | Wencel PL et al. | β | 2023 | β |
| Gold nanoparticles application to the treatment of brain dysfunctions related to metabolic diseases: evidence from experimental studies. | Silveira PCL et al. | β | 2023 | β |
| Have We Been Underestimating Modifiable Dementia Risk? An Alternative Approach for Calculating the Combined Population Attributable Fraction for Modifiable Dementia Risk Factors. | Welberry HJ et al. | β | 2023 | β |
| How should we manage hypertension and dyslipidemia to maintain cognitive function in older adults? | Akasaki Y et al. | β | 2023 | β |
| Hypertension and cognitive dysfunction: a narrative review. | Cheon EJ | β | 2023 | β |
| Impact of excessive abdominal obesity on brain microstructural abnormality in schizophrenia | Yamada S et al. | β | 2023 | β |
| Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise. | Yin F | β | 2023 | β |
| Lower Body Mass Index at Baseline Is Related to Steeper Cognitive Decline in the Alzheimer's Disease Neuroimaging Initiative Cohort. | Haley AP et al. | β | 2023 | β |
| Metabolically Healthy Overweight and Obesity, Transition to Metabolically Unhealthy Status and Cognitive Function: Results from the Framingham Offspring Study. | Kouvari M et al. | β | 2023 | β |
| Metabolic Syndrome: A Narrative Review from the Oxidative Stress to the Management of Related Diseases. | Martemucci G et al. | β | 2023 | β |
| Modifiable cardiovascular risk factors and genetics for targeted prevention of dementia. | Juul Rasmussen I et al. | β | 2023 | β |
| Newer glucose-lowering drugs and risk of dementia: A systematic review and meta-analysis of observational studies. | Tang H et al. | β | 2023 | β |
| Obesity impacts the expression of Alzheimer's disease-related genes: The Framingham Heart Study. | Charisis S et al. | β | 2023 | β |
| Pathogenesis of Chronic Kidney Disease Is Closely Bound up with Alzheimer's Disease, Especially via the Renin-Angiotensin System. | Ma K et al. | β | 2023 | β |
| Paving the Way for Alzheimer's Disease Prevention: A Systematic Review of Global Open-Access Neuroimaging Datasets in Healthy Individuals. | Ly M et al. | β | 2023 | β |
| Relationship Between Adipokines, Cognition, and Brain Structures in Old Age Depending on Obesity. | Ha J et al. | β | 2023 | β |
| Relationships Between Body Composition and Cognitive Impairment in Hospitalised Middle-Aged Type 2 Diabetic Patients. | Li YS et al. | β | 2023 | β |
| Residential greenness and risk of incident dementia: A prospective study of 375,342 participants. | Hu HY et al. | β | 2023 | β |
| Sex Differences in Cognition Across Aging. | Lee BH et al. | β | 2023 | β |
| Sex Differences in Dementia. | Hogervorst E et al. | β | 2023 | β |
| The amyloid cascade hypothesis: an updated critical review. | Kepp KP et al. | β | 2023 | β |
| The association between regional adiposity, cognitive function, and dementia-related brain changes: a systematic review. | Boccara E et al. | β | 2023 | β |
| The Effects of Amyloid-Ξ² on Metabolomic Profiles of Cardiomyocytes and Coronary Endothelial Cells. | Jang S et al. | β | 2023 | β |
| The Joint Effect of Body Mass Index and Serum Lipid Levels on Incident Dementia among Community-Dwelling Older Adults. | Lei Q et al. | β | 2023 | β |
| The Lipid Invasion Model: Growing Evidence for This New Explanation of Alzheimer's Disease. | Rudge JD | β | 2023 | β |
| The relationship between midlife dyslipidemia and lifetime incidence of dementia: A systematic review and meta-analysis of cohort studies. | Wee J et al. | β | 2023 | β |
| A New Hypothesis for Alzheimer's Disease: The Lipid Invasion Model. | Rudge JD | β | 2022 | β |
| Annual Trends in the Incidence and Prevalence of Alzheimer's Disease in South Korea: A Nationwide Cohort Study. | Baek MS et al. | β | 2022 | β |
| A Novel Ketone-Supplemented Diet Improves Recognition Memory and Hippocampal Mitochondrial Efficiency in Healthy Adult Mice. | Saito ER et al. | β | 2022 | β |
| Association Between Body Mass Index and Cognitive Function in Mild Cognitive Impairment Regardless of APOE Ξ΅4 Status. | Mun YS et al. | β | 2022 | β |
| Association Between Cholinesterase Inhibitors and New-Onset Heart Failure in Patients With Alzheimer's Disease: A Nationwide Propensity Score Matching Study. | Hsieh MJ et al. | β | 2022 | β |
| Association of Vascular Risk Scores and Cognitive Performance in a Diverse Cohort: The Multi-Ethnic Study of Atherosclerosis. | Schaich CL et al. | β | 2022 | β |
| Beta-Amyloid Instigates Dysfunction of Mitochondria in Cardiac Cells. | Jang S et al. | β | 2022 | β |
| Body mass index and risk of Parkinson, Alzheimer, Dementia, and Dementia mortality: a systematic review and dose-response meta-analysis of cohort studies among 5 million participants. | Rahmani J et al. | β | 2022 | β |
| Body weight variability and the risk of dementia in patients with type 2 diabetes mellitus: A nationwide cohort study in Korea. | Park KY et al. | β | 2022 | β |
| Changes in Adiposity and Cerebrospinal Fluid Biomarkers Following a Modified Mediterranean Ketogenic Diet in Older Adults at Risk for Alzheimer's Disease. | Brinkley TE et al. | β | 2022 | β |
| Cognitive Benefits of Physical Exercise, Physical-Cognitive Training, and Technology-Based Intervention in Obese Individuals with and without Postmenopausal Condition: A Narrative Review. | Keawtep P et al. | β | 2022 | β |
| Dementia-Preventing Behavior Awareness and Uptake Rates among Japanese Women in Midlife: A Survey-Based Pilot Study. | Suzuki Y et al. | β | 2022 | β |
| Does Neuroinflammation Underlie the Cognitive Changes Observed With Dietary Interventions? | Robbins JP et al. | β | 2022 | β |
| Effect of a Vegan Diet on Alzheimer's Disease. | Katonova A et al. | β | 2022 | β |
| Effect of Metabolic Syndrome on the Incidence of Dementia Based on National Insurance Data in Korea. | Yoo H et al. | β | 2022 | β |
| Effects of intermittent (5:2) or continuous energy restriction on basal and postprandial metabolism: a randomised study in normal-weight, young participants. | Gao Y et al. | β | 2022 | β |
| Effects of ketogenic diet on cognitive functions of mice fed high-fat-high-cholesterol diet. | Lin DT et al. | β | 2022 | β |
| Exploring links between 2-oxoglutarate-dependent oxygenases and Alzheimer's disease. | Liu H et al. | β | 2022 | β |
| Higher body mass index is associated with worse hippocampal vasoreactivity to carbon dioxide. | Glodzik L et al. | β | 2022 | β |
| Identification of Potential Targets Linked to the Cardiovascular/Alzheimer's Axis through Bioinformatics Approaches. | AndΓΊjar-Vera F et al. | β | 2022 | β |
| Independent effect of body mass index variation on amyloid-Ξ² positivity. | Kang SH et al. | β | 2022 | β |
| Ischemia as a common trigger for Alzheimer's disease. | Elman-Shina K et al. | β | 2022 | β |
| Loneliness, Not Social Support, Is Associated with Cognitive Decline and Dementia Across Two Longitudinal Population-Based Cohorts. | Freak-Poli R et al. | β | 2022 | β |
| Maternal High-Energy Diet during Pregnancy and Lactation Impairs Neurogenesis and Alters the Behavior of Adult Offspring in a Phenotype-Dependent Manner. | FabianovΓ‘ K et al. | β | 2022 | β |
| Mediation effects of diabetes and inflammation on the relationship of obesity to cognitive impairment in African Americans. | Abi Saleh R et al. | β | 2022 | β |
| Modified dementia risk score as a tool for the prediction of dementia: a prospective cohort study of 239745 participants. | Wang ZT et al. | β | 2022 | β |
| Obesity is associated with greater cognitive function in patients with type 2 diabetes mellitus. | Xing Z et al. | β | 2022 | β |
| Obesity risk is associated with altered cerebral glucose metabolism and decreased ΞΌ-opioid and CB<sub>1</sub> receptor availability. | Kantonen T et al. | β | 2022 | β |
| Pathogenesis, Murine Models, and Clinical Implications of Metabolically Healthy Obesity. | Cho YK et al. | β | 2022 | β |
| Physical activity in leisure time and at work and risk of dementia: A prospective cohort study of 117,616 individuals. | Juul Rasmussen I et al. | β | 2022 | β |
| Protective effect of olive leaves phenolic compounds against neurodegenerative disorders: Promising alternative for Alzheimer and Parkinson diseases modulation. | Hadrich F et al. | β | 2022 | β |
| Receipt of Overactive Bladder Drugs and Incident Dementia: A Population-based Case-control Study. | Matta R et al. | β | 2022 | β |
| Relationships between educational attainment, hypertension, and amyloid negative subcortical vascular dementia: The brain-battering hypothesis. | Hwangbo S et al. | β | 2022 | β |
| Sex Differences in Hypothalamic Changes and the Metabolic Response of TgAPP Mice to a High Fat Diet. | Freire-Regatillo A et al. | β | 2022 | β |
| Single-cell profiling of vascular endothelial cells reveals progressive organ-specific vulnerabilities during obesity. | Bondareva O et al. | β | 2022 | β |
| Sleeve Gastrectomy Reduces Glycemia but Does Not Affect Cognitive Impairment in Lean 5xFAD Mice. | Samuel I et al. | β | 2022 | β |
| Stability in BMI over time is associated with a better cognitive trajectory in older adults. | Beeri MS et al. | β | 2022 | β |
| Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease. | Austad SN et al. | β | 2022 | β |
| The Cognitive Improvement and Alleviation of Brain Hypermetabolism Caused by FFAR3 Ablation in Tg2576 Mice Is Persistent under Diet-Induced Obesity. | Solas M et al. | β | 2022 | β |
| The effect of a high-polyphenol Mediterranean diet (Green-MED) combined with physical activity on age-related brain atrophy: the Dietary Intervention Randomized Controlled Trial Polyphenols Unprocessed Study (DIRECT PLUS). | Kaplan A et al. | β | 2022 | β |
| The impact of age, sex, cardio-respiratory fitness, and cardiovascular disease risk on dynamic cerebral autoregulation and baroreflex sensitivity. | Maxwell JD et al. | β | 2022 | β |
| The Use of Digital Technology to Assess Cognitive Function in Tunisian Adults. | Boujelbane MA et al. | β | 2022 | β |
| A High Fat/Cholesterol Diet Recapitulates Some Alzheimer's Disease-Like Features in Mice: Focus on Hippocampal Mitochondrial Dysfunction. | Mancini G et al. | β | 2021 | β |
| Amyloid Beta Peptide Is an Endogenous Negative Allosteric Modulator of Leptin Receptor. | Cecon E et al. | β | 2021 | β |
| A Review of miRNAs as Biomarkers and Effect of Dietary Modulation in Obesity Associated Cognitive Decline and Neurodegenerative Disorders. | Perdoncin M et al. | β | 2021 | β |
| Association Between Childhood Neighborhood Quality and the Risk of Cognitive Dysfunction in Chinese Middle-Aged and Elderly Population: The Moderation Effect of Body Mass Index. | Xiong P et al. | β | 2021 | β |
| Association Between Midlife Obesity and Its Metabolic Consequences, Cerebrovascular Disease, and Cognitive Decline. | Morys F et al. | β | 2021 | β |
| Association of a Total Cholesterol Polygenic Score with Cholesterol Levels and Pathological Biomarkers across the Alzheimer's Disease Spectrum. | Nilsson NIV et al. | β | 2021 | β |
| Association of Drug Application and Hydration Status in Elderly Patients. | Hoen L et al. | β | 2021 | β |
| Association of Early Ξ²-Amyloid Accumulation and Neuroinflammation Measured With [<sup>11</sup>C]PBR28 in Elderly Individuals Without Dementia. | Toppala S et al. | β | 2021 | β |
| Associations between body composition and cognitive function in an elderly Korean population: A cohort-based cross-sectional study. | Seo YK et al. | β | 2021 | β |
| Associations Between Obesity and Alzheimer's Disease: Multiple Bioinformatic Analyses. | Zhuang QS et al. | β | 2021 | β |
| Associations of Body Mass Index, Visceral Fat Area, Waist Circumference, and Waist-to-Hip Ratio with Cognitive Function in Western China: Results from WCHAT Study. | Liu X et al. | β | 2021 | β |
| Associations of dietary markers with brain volume and connectivity: A systematic review of MRI studies. | Jensen DEA et al. | β | 2021 | β |
| Attenuative Effects of Fluoxetine and <i>Triticum aestivum</i> against Aluminum-Induced Alzheimer's Disease in Rats: The Possible Consequences on Hepatotoxicity and Nephrotoxicity. | Abu-Elfotuh K et al. | β | 2021 | β |
| Brain insulin, insulin-like growth factor 1 and glucagon-like peptide 1 signalling in Alzheimer's disease. | Ferreira ST | β | 2021 | β |
| Causal Association Between Heart Failure and Alzheimer's Disease: A Two-Sample Bidirectional Mendelian Randomization Study. | Duan C et al. | β | 2021 | β |
| "Cerebral small vessel disease and other influential factors of cognitive impairment in the middle-aged: a long-term observational cohort PURE-MIND study in Poland". | SzczeΕniak D et al. | β | 2021 | β |
| Changes in cerebral perfusion following a 12-month exercise and diet intervention. | Stillman CM et al. | β | 2021 | β |
| Cholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets. | Dai L et al. | β | 2021 | β |
| Cognitive Trajectories in Comorbid Dementia With Schizophrenia or Bipolar Disorder: The South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLaM BRC) Case Register. | Bendayan R et al. | β | 2021 | β |
| Crosstalk between Heart Failure and Cognitive Impairment via hsa-miR-933/RELB/CCL21 Pathway. | Feng W et al. | β | 2021 | β |
| Dissecting Sex-Related Cognition between Alzheimer's Disease and Diabetes: From Molecular Mechanisms to Potential Therapeutic Strategies. | Ashraf GM et al. | β | 2021 | β |
| Evaluation of High Cholesterol and Risk of Dementia and Cognitive Decline in Older Adults Using Individual Patient Meta-Analysis. | Peters R et al. | β | 2021 | β |
| Five-Year Change in Body Mass Index Predicts Conversion to Mild Cognitive Impairment or Dementia Only in APOE Ι4 Allele Carriers. | Kadey KR et al. | β | 2021 | β |
| Four Weeks of Detraining Induced by COVID-19 Reverse Cardiac Improvements from Eight Weeks of Fitness-Dance Training in Older Adults with Mild Cognitive Impairment. | Ammar A et al. | β | 2021 | β |
| Gut Microbiome, Inflammation, and Cerebrovascular Function: Link Between Obesity and Cognition. | Olsthoorn L et al. | β | 2021 | β |
| High Caloric Diet Induces Memory Impairment and Disrupts Synaptic Plasticity in Aged Rats. | Paulo SL et al. | β | 2021 | β |
| High-fat diet alters stress behavior, inflammatory parameters and gut microbiota in Tg APP mice in a sex-specific manner. | Yanguas-CasΓ‘s N et al. | β | 2021 | β |
| High fat diet and its effects on cognitive health: alterations of neuronal and vascular components of brain. | Sharma S | β | 2021 | β |
| How can dementia and disability be prevented in older adults: where are we today and where are we going? | Lisko I et al. | β | 2021 | β |
| Hypolipidemic effects of Hypericum Scabrum extract on the serum lipid profile and obesity in high-fat diet fed rats. | Faraji N et al. | β | 2021 | β |
| Hypoxia and brain aging: Neurodegeneration or neuroprotection? | Burtscher J et al. | β | 2021 | β |
| Impact of Cardiovascular Risk Factors in Adolescence, Young Adulthood, and Midlife on Late-Life Cognition: Study of Healthy Aging in African Americans. | George KM et al. | β | 2021 | β |
| Impact of High Altitude on Cardiovascular Health: Current Perspectives. | Mallet RT et al. | β | 2021 | β |
| Interactions between reproductive transitions during aging and addiction: promoting translational crosstalk between different fields of research. | Gipson CD et al. | β | 2021 | β |
| Investigating the relationship between BMI across adulthood and late life brain pathologies. | Lane CA et al. | β | 2021 | β |
| Leptin regulation of hippocampal synaptic function in health and disease. | Hamilton K et al. | β | 2021 | β |
| Longitudinal Body Weight Change, Visit-To-Visit Body Weight Fluctuation, and Cognitive Decline Among Older Adults. | Lan YT et al. | β | 2021 | β |
| Long-term dysglycemia as a risk factor for faster cognitive decline during aging: A 12-year follow-up study. | Rotonen S et al. | β | 2021 | β |
| Metabolically healthy obesity and lipids may be protective factors for pathological changes of alzheimer's disease in cognitively normal adults. | Huang SJ et al. | β | 2021 | β |
| Metabolic Syndrome and Cardiovascular Disease Impacts on the Pathophysiology and Phenotype of HIV-Associated Neurocognitive Disorders. | Moulignier A et al. | β | 2021 | β |
| Metabolic Syndrome and Cognitive Function in Midlife. | Foret JT et al. | β | 2021 | β |
| Metabolic syndrome and cognitive performance across the adult lifespan. | Haase Alasantro L et al. | β | 2021 | β |
| Metabolic syndrome components moderate the association between executive function and functional connectivity in the default mode network. | Foret JT et al. | β | 2021 | β |
| Mild Cognitive Impairment and modifiable risk factors among Lebanese older adults in primary care. | Assaf G et al. | β | 2021 | β |
| Multi-domain interventions for the prevention of dementia and cognitive decline. | Hafdi M et al. | β | 2021 | β |
| Nanotechnology as a therapeutic strategy to prevent neuropsychomotor alterations associated with hypercholesterolemia. | Rodrigues MS et al. | β | 2021 | β |
| Nerve Growth Factor-Based Therapy in Alzheimer's Disease and Age-Related Macular Degeneration. | Amadoro G et al. | β | 2021 | β |
| Network Modeling Sex Differences in Brain Integrity and Metabolic Health. | Foret JT et al. | β | 2021 | β |
| Obesity is associated with reduced cerebral blood flow - modified by physical activity. | Knight SP et al. | β | 2021 | β |
| Private Insurance and Mental Health among Older Adults with Multiple Chronic Conditions: A Longitudinal Analysis by Race and Ethnicity. | Jun H et al. | β | 2021 | β |
| Promoting Successful Cognitive Aging: A Ten-Year Update. | Krivanek TJ et al. | β | 2021 | β |
| Racial/Ethnic Disparities in Young Adulthood and Midlife Cardiovascular Risk Factors and Late-life Cognitive Domains: The Kaiser Healthy Aging and Diverse Life Experiences (KHANDLE) Study. | Peterson RL et al. | β | 2021 | β |
| Relationship of Neighborhood Greenness to Alzheimer's Disease and Non-Alzheimer's Dementia Among 249,405 U.S. Medicare Beneficiaries. | Aitken WW et al. | β | 2021 | β |
| Role of Exendin-4 in Brain Insulin Resistance, Mitochondrial Function, and Neurite Outgrowth in Neurons under Palmitic Acid-Induced Oxidative Stress. | Jo D et al. | β | 2021 | β |
| Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors vs. Dipeptidyl Peptidase-4 (DPP4) Inhibitors for New-Onset Dementia: A Propensity Score-Matched Population-Based Study With Competing Risk Analysis. | Mui JV et al. | β | 2021 | β |
| The Burden of Dementia due to Down Syndrome, Parkinson's Disease, Stroke, and Traumatic Brain Injury: A Systematic Analysis for the Global Burden of Disease Study 2019. | GBD 2019 Dementia Collaborators | β | 2021 | β |
| The Emerging Role of COX-2, 15-LOX and PPARΞ³ in Metabolic Diseases and Cancer: An Introduction to Novel Multi-target Directed Ligands (MTDLs). | Alaaeddine RA et al. | β | 2021 | β |
| The Endocannabinoid System: A Bridge between Alzheimer's Disease and Gut Microbiota. | Bisogno T et al. | β | 2021 | β |
| The Impact of Obesity on Microglial Function: Immune, Metabolic and Endocrine Perspectives. | Alexaki VI | β | 2021 | β |
| The joint association of physical activity and fine particulate matter exposure with incident dementia in elderly Hong Kong residents. | Ran J et al. | β | 2021 | β |
| The risk of Alzheimer's disease according to dynamic changes in metabolic health and obesity: a nationwide population-based cohort study. | Cho YK et al. | β | 2021 | β |
| Western diet as a trigger of Alzheimer's disease: From metabolic syndrome and systemic inflammation to neuroinflammation and neurodegeneration. | WiΔckowska-Gacek A et al. | β | 2021 | β |
| Western Diet Induces Impairment of Liver-Brain Axis Accelerating Neuroinflammation and Amyloid Pathology in Alzheimer's Disease. | WiΘ©ckowska-Gacek A et al. | β | 2021 | β |
| Adipose-Derived Molecules-Untouched Horizons in Alzheimer's Disease Biology. | Pichiah PBT et al. | β | 2020 | β |
| Adipose Tissue and Brain Metabolic Responses to Western Diet-Is There a Similarity between the Two? | Mazzoli A et al. | β | 2020 | β |
| Alzheimer's/Vascular Spectrum Dementia: Classification in Addition to Diagnosis. | Emrani S et al. | β | 2020 | β |
| Amyloid-beta burden predicts prospective decline in body mass index in clinically normal adults. | Rabin JS et al. | β | 2020 | β |
| Animal Models of Metabolic Disorders in the Study of Neurodegenerative Diseases: An Overview. | de Bem AF et al. | β | 2020 | β |
| An Overview on the Associations between Health Behaviors and Brain Health in Children and Adolescents with Special Reference to Diet Quality. | Naveed S et al. | β | 2020 | β |
| A review of the relationship between eating behavior, obesity and functional brain network organization. | Donofry SD et al. | β | 2020 | β |
| Association of body mass index with risk of cognitive impairment and dementia: A systematic review and meta-analysis of prospective studies. | Qu Y et al. | β | 2020 | β |
| Association of Low Systolic Blood Pressure with Postmortem Amyloid-Ξ² and Tau. | Oveisgharan S et al. | β | 2020 | β |
| Association of mild cognitive impairment and metabolic syndrome in patients with hypertension. | Mehra A et al. | β | 2020 | β |
| Associations of BMI and Serum Urate with Developing Dementia: A Prospective Cohort Study. | Cao Z et al. | β | 2020 | β |
| Body mass index is associated with smaller medial temporal lobe volume in those at risk for Alzheimer's disease. | Hayes JP et al. | β | 2020 | β |
| Body Weight Variability Increases Dementia Risk Among Older Adults: A Nationwide Population-Based Cohort Study. | Roh E et al. | β | 2020 | β |
| Cerebrovascular Changes and Neurodegeneration Related to Hyperlipidemia: Characteristics of the Human ApoB-100 Transgenic Mice. | TΓ³th ME et al. | β | 2020 | β |
| Co-Prevalence of Alzheimer's Disease and Age-Related Macular Degeneration Established by Histopathologic Diagnosis. | Schwaber EJ et al. | β | 2020 | β |
| Dementia risk by combinations of metabolic diseases and body mass index: Japan Gerontological Evaluation Study Cohort Study. | Yokomichi H et al. | β | 2020 | β |
| Diabetic phenotype in mouse and humans reduces the number of microglia around Ξ²-amyloid plaques. | Natunen T et al. | β | 2020 | β |
| Diet, Microbiota and Brain Health: Unraveling the Network Intersecting Metabolism and Neurodegeneration. | Gentile F et al. | β | 2020 | β |
| Docosahexaenoic Acid-Rich Fish Oil Supplementation Reduces Kinase Associated with Insulin Resistance in Overweight and Obese Midlife Adults. | Thota RN et al. | β | 2020 | β |
| Effects of Long-Term Endurance Exercise and Lithium Treatment on Neuroprotective Factors in Hippocampus of Obese Rats. | Park J et al. | β | 2020 | β |
| Effects of oxidized low-density lipoprotein on differentiation of mouse neural progenitor cells into neural cells. | Ishizuka T et al. | β | 2020 | β |
| Evaluating Combined Precursor Isotopic Labeling and Isobaric Tagging Performance on Orbitraps To Study the Peripheral Proteome of Alzheimer's Disease. | King CD et al. | β | 2020 | β |
| Executive functioning and disinhibited eating in children and adolescents. | Kelly NR et al. | β | 2020 | β |
| Higher risk of dementia in English older individuals who are overweight or obese. | Ma Y et al. | β | 2020 | β |
| High fat diet worsens Alzheimer's disease-related behavioral abnormalities and neuropathology in APP/PS1 mice, but not by synergistically decreasing cerebral blood flow. | Bracko O et al. | β | 2020 | β |
| Impact of Acute and Chronic Amyloid-Ξ² Peptide Exposure on Gut Microbial Commensals in the Mouse. | Dos Santos Guilherme M et al. | β | 2020 | β |
| Incident prolonged QT interval in midlife and late-life cognitive performance. | Suemoto CK et al. | β | 2020 | β |
| Increased levels of AΞ²42 decrease the lifespan of ob/ob mice with dysregulation of microglia and astrocytes. | Shinohara M et al. | β | 2020 | β |
| Inflammation: major denominator of obesity, Type 2 diabetes and Alzheimer's disease-like pathology? | KacΓΕovΓ‘ M et al. | β | 2020 | β |
| Investigating spatial convergence of diagnosed dementia, depression and type 2 diabetes prevalence in West Adelaide, Australia. | Aw JYH et al. | β | 2020 | β |
| Level of body fat relates to memory decline and interacts with age in its association with hippocampal and subcortical atrophy. | Nyberg CK et al. | β | 2020 | β |
| Lifestyle intervention to prevent Alzheimer's disease. | Ko Y et al. | β | 2020 | β |
| Low Cholesterol Level Linked to Reduced Semantic Fluency Performance and Reduced Gray Matter Volume in the Medial Temporal Lobe. | Yang FN et al. | β | 2020 | β |
| Main and interacting effects of physical activity and sedentary time on older adults' BMI: The moderating roles of socio-demographic and environmental attributes. | Van Dyck D et al. | β | 2020 | β |
| Metabolic Stress Alters Antioxidant Systems, Suppresses the Adiponectin Receptor 1 and Induces Alzheimer's Like Pathology in Mice Brain. | Hahm JR et al. | β | 2020 | β |
| Microglia, Lifestyle Stress, and Neurodegeneration. | Madore C et al. | β | 2020 | β |
| Multidomain Interventions to Prevent Cognitive Impairment, Alzheimer's Disease, and Dementia: From FINGER to World-Wide FINGERS. | Rosenberg A et al. | β | 2020 | β |
| Neuromodulation of the prefrontal cortex facilitates diet-induced weight loss in midlife women: a randomized, proof-of-concept clinical trial. | Amo Usanos C et al. | β | 2020 | β |
| Obesity and the Brain: Another Brain-Body Versus Body-Brain Conundrum. | Haley AP | β | 2020 | β |
| Paeonol, an Ingredient of Kamishoyosan, Reduces Intracellular Lipid Accumulation by Inhibiting Glucocorticoid Receptor Activity in 3T3-L1 Cells. | Izumi M et al. | β | 2020 | β |
| Palmitate Is Increased in the Cerebrospinal Fluid of Humans with Obesity and Induces Memory Impairment in Mice via Pro-inflammatory TNF-Ξ±. | Melo HM et al. | β | 2020 | β |
| Perceived weight discrimination and performance in five domains of cognitive function. | Sutin AR et al. | β | 2020 | β |
| Physical Activity for Executive Function and Activities of Daily Living in AD Patients: A Systematic Review and Meta-Analysis. | Zhu L et al. | β | 2020 | β |
| Preclinical models of disease and multimorbidity with focus upon cardiovascular disease and dementia. | Shabir O et al. | β | 2020 | β |
| Premature natural menopause and cognitive function among older women in Indonesia. | Sujarwoto S et al. | β | 2020 | β |
| Prevention of dementia in an ageing world: Evidence and biological rationale. | Grande G et al. | β | 2020 | β |
| Regulatory microRNAs and vascular cognitive impairment and dementia. | Zhang J et al. | β | 2020 | β |
| Renal Contributions in the Pathophysiology and Neuropathological Substrates Shared by Chronic Kidney Disease and Alzheimer's Disease. | Stanciu GD et al. | β | 2020 | β |
| Role of Insulin Resistance in the Alzheimer's Disease Progression. | Nguyen TT et al. | β | 2020 | β |
| Sex differences in exercise efficacy: Is midlife a critical window for promoting healthy cognitive aging? | Barha CK et al. | β | 2020 | β |
| Sex-Related Differences in Brain Volumes and Cerebral Blood Flow Among Overweight and Obese Adults With Type 2 Diabetes: Exploratory Analyses From the Action for Health in Diabetes Brain Magnetic Resonance Imaging Study. | Espeland MA et al. | β | 2020 | β |
| Tempe, Tofu, and Amyloid-Ξ² 1-40 Serum Levels in Ovariectomized Rats. | Kridawati A et al. | β | 2020 | β |
| The Unraveling: Cardiac and Musculoskeletal Defects and Their Role in Common Alzheimer Disease Morbidity and Mortality. | Suryadevara V et al. | β | 2020 | β |
| Trends in the public health significance, definitions of disease, and implications for prevention of Alzheimer's disease. | Derby CA | β | 2020 | β |
| Type 3 Diabetes and Its Role Implications in Alzheimer's Disease. | Nguyen TT et al. | β | 2020 | β |
| Unwinding Complexities of Diabetic Alzheimer by Potent Novel Molecules. | Gupta S et al. | β | 2020 | β |
| Variability in body weight precedes diagnosis in dementia: A nationwide cohort study. | Ha J et al. | β | 2020 | β |
| White matter inflammation and cognitive function in a co-morbid metabolic syndrome and prodromal Alzheimer's disease rat model. | Ivanova N et al. | β | 2020 | β |
| Aberrant patterns of default-mode network functional connectivity associated with metabolic syndrome: A resting-state study. | Rashid B et al. | β | 2019 | β |
| AD molecular: PET amyloid imaging across the Alzheimer's disease spectrum: From disease mechanisms to prevention. | Meyer PF et al. | β | 2019 | β |
| Aging, Metabolism, Synaptic Activity, and AΞ² in Alzheimer's Disease. | Gouras GK | β | 2019 | β |
| Alterations in cholesterol metabolism as a risk factor for developing Alzheimer's disease: Potential novel targets for treatment. | Loera-Valencia R et al. | β | 2019 | β |
| A Population Perspective on Prevention of Dementia. | Eggink E et al. | β | 2019 | β |
| A Randomized Controlled Trial of Adherence to a 24-Month Home-Based Physical Activity Program and the Health Benefits for Older Adults at Risk of Alzheimer's Disease: The AIBL Active-Study. | Cox KL et al. | β | 2019 | β |
| Are Psycho-Behavioral Factors Accounting for Longevity? | FernΓ‘ndez-Ballesteros R et al. | β | 2019 | β |
| Association between adiposity levels and cognitive impairment in the Chilean older adult population. | Concha-Cisternas Y et al. | β | 2019 | β |
| Association Between Waist Circumference and Dementia in Older Persons: A Nationwide Population-Based Study. | Cho GJ et al. | β | 2019 | β |
| Association of Midlife Cardiovascular Risk Profiles With Cerebral Perfusion at Older Ages. | Suri S et al. | β | 2019 | β |
| Association of muscle and visceral adipose tissues with the probability of Alzheimer's disease in healthy subjects. | Kim J et al. | β | 2019 | β |
| Associations between obesity and cognitive impairment in the Chinese elderly: an observational study. | Hou Q et al. | β | 2019 | β |
| Attenuation of metabolic syndrome in the ob/ob mouse model by resistant starch intervention is dose dependent. | Wang A et al. | β | 2019 | β |
| BMI-associated gene variants in <i>FTO</i> and cardiometabolic and brain disease: obesity or pleiotropy? | Ganeff IMM et al. | β | 2019 | β |
| Body Weight Variation Patterns as Predictors of Cognitive Decline over a 5 Year Follow-Up among Community-Dwelling Elderly (MAPT Study). | Giudici KV et al. | β | 2019 | β |
| Cardiovascular Disease and Frailty: What Are the Mechanistic Links? | Stewart R | β | 2019 | β |
| Combining modifiable risk factors and risk of dementia: a systematic review and meta-analysis. | Peters R et al. | β | 2019 | β |
| Comprehensive and Systematic Analysis of Gene Expression Patterns Associated with Body Mass Index. | Joseph PV et al. | β | 2019 | β |
| Current and emerging avenues for Alzheimer's disease drug targets. | Loera-Valencia R et al. | β | 2019 | β |
| Development and psychometric properties of the Healthy Aging Activity Engagement Scale (HAAE). | Schmitter-Edgecombe M et al. | β | 2019 | β |
| Diabesity and brain disturbances: A metabolic perspective. | Cardoso S et al. | β | 2019 | β |
| Differential Methylation in <i>APOE</i> (Chr19; Exon Four; from 44,909,188 to 44,909,373/hg38) and Increased Apolipoprotein E Plasma Levels in Subjects with Mild Cognitive Impairment. | Mancera-PΓ‘ez O et al. | β | 2019 | β |
| Early and reversible changes to the hippocampal proteome in mice on a high-fat diet. | McLean FH et al. | β | 2019 | β |
| Effect of late-life weight change on dementia incidence: a 10-year cohort study using claim data in Korea. | Park S et al. | β | 2019 | β |
| Genetic background modifies phenotypic and transcriptional responses in a C. elegans model of Ξ±-synuclein toxicity. | Wang YA et al. | β | 2019 | β |
| Genetic basis of motoric cognitive risk syndrome in the Health and Retirement Study. | Sathyan S et al. | β | 2019 | β |
| Getting to the Heart of Alzheimer Disease. | Tublin JM et al. | β | 2019 | β |
| Higher Body Mass Index Is Associated with Lower Cortical Amyloid-Ξ² Burden in Cognitively Normal Individuals in Late-Life. | Thirunavu V et al. | β | 2019 | β |
| High serum high-density lipoprotein-cholesterol is associated with memory function and gyrification of insular and frontal opercular cortex in an elderly memory-clinic population. | Kinno R et al. | β | 2019 | β |
| Hours of work and health in Japan. | Okamoto S | β | 2019 | β |
| Hypertension and obesity moderate the relationship between Ξ²-amyloid and cognitive decline in midlife. | Clark LR et al. | β | 2019 | β |
| Importance of Increasing Modifiable Risk Factors Knowledge on Alzheimer's Disease Among Community Pharmacists and General Practitioners in Spain. | Alacreu M et al. | β | 2019 | β |
| Incidence of dementia after age 90 in a multiracial cohort. | Gilsanz P et al. | β | 2019 | β |
| Is Alzheimer's Disease Risk Modifiable? | Serrano-Pozo A et al. | β | 2019 | β |
| Is Fat Mass Cross-Sectionally Associated with Cortical AΞ² Load in the Human Brain? | Maltais M et al. | β | 2019 | β |
| Linking late life depression and Alzheimer's disease: mechanisms and resilience. | Weisenbach SL et al. | β | 2019 | β |
| Mediterranean and MIND Diets Containing Olive Biophenols Reduces the Prevalence of Alzheimer's Disease. | Omar SH | β | 2019 | β |
| Metabolic Syndrome, Mild Cognitive Impairment, and Dementia: A Meta-Analysis of Longitudinal Studies. | Atti AR et al. | β | 2019 | β |
| Midlife adiposity predicts cognitive decline in the prospective Multicenter AIDS Cohort Study. | Rubin LH et al. | β | 2019 | β |
| miRDRN-miRNA disease regulatory network: a tool for exploring disease and tissue-specific microRNA regulatory networks. | Liu HC et al. | β | 2019 | β |
| Novel Therapeutic Potentials of Taxifolin for Amyloid-Ξ²-associated Neurodegenerative Diseases and Other Diseases: Recent Advances and Future Perspectives. | Tanaka M et al. | β | 2019 | β |
| Obesity and Longer Term Risks of Dementia in 65-74 Year Olds. | Bowman K et al. | β | 2019 | β |
| Obesity as a Risk Factor for Alzheimer's Disease: Implication of Leptin and Glutamate. | Lloret A et al. | β | 2019 | β |
| On entropy and information in gene interaction networks. | Wallace ZS et al. | β | 2019 | β |
| Pathological and cognitive changes in patients with type 2 diabetes mellitus and comorbid MCI and protective hypoglycemic therapies: a narrative review. | Zhang X et al. | β | 2019 | β |
| Progression to dementia in memory clinic patients with mild cognitive impairment and normal Ξ²-amyloid. | Rosenberg A et al. | β | 2019 | β |
| Relationship between adiposity parameters and cognition: the "fat and jolly" hypothesis in middle-aged and elderly people in China. | Zhang L et al. | β | 2019 | β |
| Risk of Incident Dementia According to Metabolic Health and Obesity Status in Late Life: A Population-Based Cohort Study. | Lee JY et al. | β | 2019 | β |
| Study rationale and protocol of the BARICO study: a longitudinal, prospective, observational study to evaluate the effects of weight loss on brain function and structure after bariatric surgery. | Vreeken D et al. | β | 2019 | β |
| Targeting Trim69 alleviates high fat diet (HFD)-induced hippocampal injury in mice by inhibiting apoptosis and inflammation through ASK1 inactivation. | Li LJ et al. | β | 2019 | β |
| The Association of Late-Life Diabetes Status and Hyperglycemia With Incident Mild Cognitive Impairment and Dementia: The ARIC Study. | Rawlings AM et al. | β | 2019 | β |
| The Complex Interactions Between Obesity, Metabolism and the Brain. | Uranga RM et al. | β | 2019 | β |
| The Effects of Leptin on Glial Cells in Neurological Diseases. | Fujita Y et al. | β | 2019 | β |
| The gender- and age- dependent relationships between serum lipids and cognitive impairment: a cross-sectional study in a rural area of Xi'an, China. | Zhao B et al. | β | 2019 | β |
| The Prevalence of Overweight and Obesity in an Adult Kuwaiti Population in 2014. | Weiderpass E et al. | β | 2019 | β |
| Transcriptome profiling of brain myeloid cells revealed activation of Itgal, Trem1, and Spp1 in western diet-induced obesity. | Yang H et al. | β | 2019 | β |
| Waist Circumference and All-Cause Mortality among Older Adults in Rural Indonesia. | Pujilestari CU et al. | β | 2019 | β |
| A 10-Year Follow-Up of Adiposity and Dementia in Swedish Adults Aged 70 Years and Older. | Arnoldussen IAC et al. | β | 2018 | β |
| Albuminuria and Microalbuminuria asΒ Predictors of Cognitive Performance inΒ aΒ General Population: An 11-Year Follow-Up Study. | Ekblad LL et al. | β | 2018 | β |
| AMP-activated Protein Kinase Controls Immediate Early Genes Expression Following Synaptic Activation Through the PKA/CREB Pathway. | Didier S et al. | β | 2018 | β |
| Amylin in Alzheimer's disease: Pathological peptide or potential treatment? | Mietlicki-Baase EG | β | 2018 | β |
| Associations of Genetic Susceptibility to Alzheimer's Disease with Adiposity and Cardiometabolic Risk Factors among Children in a 2-Year Follow-up Study. | Haapala EA et al. | β | 2018 | β |
| Auditory system dysfunction in Alzheimer disease and its prodromal states: A review. | Swords GM et al. | β | 2018 | β |
| Cerebrospinal fluid Ξ²-amyloid<sub>42</sub> and neurofilament light relate to white matter hyperintensities. | Osborn KE et al. | β | 2018 | β |
| Chronic consumption of a western diet modifies the DNA methylation profile in the frontal cortex of mice. | Yokoyama AS et al. | β | 2018 | β |
| Clinical predictors of Alzheimer's disease progression. | Hishikawa N et al. | β | 2018 | β |
| Cognitive Function and Vascular Risk Factors Among Older African American Adults. | Williams IC et al. | β | 2018 | β |
| Delusions in Patients with Dementia with Lewy Bodies and the Associated Factors. | Tzeng RC et al. | β | 2018 | β |
| Dementia risk and prevention by targeting modifiable vascular risk factors. | Tariq S et al. | β | 2018 | β |
| Development of a cerebrovascular magnetic resonance imaging biomarker for cognitive aging. | Vemuri P et al. | β | 2018 | β |
| Disease-modifying effects of metabolic perturbations in ALS/FTLD. | Jawaid A et al. | β | 2018 | β |
| Disorders of Body Weight, Sleep and Circadian Rhythm as Manifestations of Hypothalamic Dysfunction in Alzheimer's Disease. | Hiller AJ et al. | β | 2018 | β |
| Does Obesity Increase the Risk of Dementia: A Literature Review. | Anjum I et al. | β | 2018 | β |
| Effect of Cholesterol on Membrane Fluidity and Association of AΞ² Oligomers and Subsequent Neuronal Damage: A Double-Edged Sword. | FernΓ‘ndez-PΓ©rez EJ et al. | β | 2018 | β |
| Effects of 90 Days of Resveratrol Supplementation on Cognitive Function in Elders: A Pilot Study. | Anton SD et al. | β | 2018 | β |
| Executive functioning and psychological symptoms in food addiction: a study among individuals with severe obesity. | Rodrigue C et al. | β | 2018 | β |
| High fat diet feeding induced insulin resistance exacerbates 6-OHDA mediated neurotoxicity and behavioral abnormalities in rats. | Sharma S et al. | β | 2018 | β |
| Insulin Resistance in Alzheimer's Disease. | Ferreira LSS et al. | β | 2018 | β |
| Insulin Resistance is Associated with Cognitive Decline Among Older Koreans with Normal Baseline Cognitive Function: A Prospective Community-Based Cohort Study. | Kong SH et al. | β | 2018 | β |
| "It ain't what you do, it's the way that you do it": does obesity affect perceptual motor control ability of adults on the speed and accuracy of a discrete aiming task? | Gaul D et al. | β | 2018 | β |
| Leptin and ghrelin: Sewing metabolism onto neurodegeneration. | de Candia P et al. | β | 2018 | β |
| Long-term impact of intensive lifestyle intervention on cognitive function assessed with the National Institutes of Health Toolbox: The Look AHEAD study. | Hayden KM et al. | β | 2018 | β |
| Maternal high-fat diet associated with altered gene expression, DNA methylation, and obesity risk in mouse offspring. | Keleher MR et al. | β | 2018 | β |
| Measured energy content of frequently purchased restaurant meals: multi-country cross sectional study. | Roberts SB et al. | β | 2018 | β |
| Mineralocorticoid receptor antagonism prevents obesity-induced cerebral artery remodeling and reduces white matter injury in rats. | Pires PW et al. | β | 2018 | β |
| mTOR drives cerebral blood flow and memory deficits in LDLR<sup>-/-</sup> mice modeling atherosclerosis and vascular cognitive impairment. | Jahrling JB et al. | β | 2018 | β |
| Obesity as a risk factor for Alzheimer's disease: weighing the evidence. | Alford S et al. | β | 2018 | β |
| Obesity trajectories and risk of dementia: 28 years of follow-up in the Whitehall II Study. | Singh-Manoux A et al. | β | 2018 | β |
| Patterns of adiposity, vascular phenotypes and cognitive function in the 1946 British Birth Cohort. | Masi S et al. | β | 2018 | β |
| Performance on the Montreal Cognitive Assessment (MoCA) in Older Adults Presenting for Bariatric Surgery. | Mohun SH et al. | β | 2018 | β |
| Phenotypic heterogeneity of obesity-related brain vulnerability: one-size interventions will not fit all. | Haley AP et al. | β | 2018 | β |
| Physical Activity in Preventing Alzheimer's Disease and Cognitive Decline: A Narrative Review. | Brini S et al. | β | 2018 | β |
| Population Neuroscience: Dementia Epidemiology Serving Precision Medicine and Population Health. | Ganguli M et al. | β | 2018 | β |
| Predicting dementia from primary care records: A systematic review and meta-analysis. | Ford E et al. | β | 2018 | β |
| Reduced vascular risk factors in Parkinson's disease dementia and dementia with Lewy bodies compared to Alzheimer's disease. | Chan PC et al. | β | 2018 | β |
| Regulation of Hippocampal Synaptic Function by the Metabolic Hormone, Leptin: Implications for Health and Neurodegenerative Disease. | McGregor G et al. | β | 2018 | β |
| Regulation of Immune Cell Function by PPARs and the Connection with Metabolic and Neurodegenerative Diseases. | Le Menn G et al. | β | 2018 | β |
| Relationships of Clinical and Computed Tomography-Imaged Adiposity with Cognition in Middle-Aged and Older African Americans. | Parker KG et al. | β | 2018 | β |
| Risk of Alzheimer's Disease in Obstructive Sleep Apnea Syndrome: Amyloid-Ξ² and Tau Imaging. | Elias A et al. | β | 2018 | β |
| Study of community-living Alzheimer's patients' adherence to the Mediterranean diet and risks of malnutrition at different disease stages. | Rocaspana-GarcΓa M et al. | β | 2018 | β |
| The Antiepileptic Ketogenic Diet Alters Hippocampal Transporter Levels and Reduces Adiposity in Aged Rats. | Hernandez AR et al. | β | 2018 | β |
| The Association Between Body Mass Index, and Cognitive, Functional, and Behavioral Declines for Incident Dementia. | Michaud TL et al. | β | 2018 | β |
| The relationship of waist circumference and body mass index to grey matter volume in community dwelling adults with mild obesity. | Hayakawa YK et al. | β | 2018 | β |
| The rising health, social and economic costs of Australia's ageing prisoner population. | Ginnivan NA et al. | β | 2018 | β |
| The Role of Leptin and Adiponectin in Obesity-Associated Cognitive Decline and Alzheimer's Disease. | Forny-Germano L et al. | β | 2018 | β |
| The Therapeutic Potential of Metformin in Neurodegenerative Diseases. | Rotermund C et al. | β | 2018 | β |
| Abdominal obesity and white matter microstructure in midlife. | Birdsill AC et al. | β | 2017 | β |
| Age-Related Changes in Gustatory, Homeostatic, Reward, and Memory Processing of Sweet Taste in the Metabolic Syndrome: An fMRI Study. | Jacobson A et al. | β | 2017 | β |
| Age, vascular health, and Alzheimer disease biomarkers in an elderly sample. | Vemuri P et al. | β | 2017 | β |
| Aging, Obesity, and Inflammatory Age-Related Diseases. | Frasca D et al. | β | 2017 | β |
| Amyloid precursor protein modulates macrophage phenotype and diet-dependent weight gain. | Puig KL et al. | β | 2017 | β |
| A Pilot Study: The Beneficial Effects of Combined Statin-exercise Therapy on Cognitive Function in Patients with Coronary Artery Disease and Mild Cognitive Decline. | Toyama K et al. | β | 2017 | β |
| Association of Hypoglycemia With Subsequent Dementia in Older Patients With Type 2 Diabetes Mellitus. | Mehta HB et al. | β | 2017 | β |
| Associations between body mass index, mid-arm circumference, calf circumference, and functional ability over time in an elderly Taiwanese population. | Tsai HJ et al. | β | 2017 | β |
| Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort. | Gottesman RF et al. | β | 2017 | β |
| Body Mass Index and Risk of Alzheimer's Disease: A Mendelian Randomization Study of 399,536 Individuals. | Nordestgaard LT et al. | β | 2017 | β |
| Body mass index in midlife and dementia: Systematic review and meta-regression analysis of 589,649 men and women followed in longitudinal studies. | Albanese E et al. | β | 2017 | β |
| Butyrate Reduces HFD-Induced Adipocyte Hypertrophy and Metabolic Risk Factors in Obese LDLr-/-.Leiden Mice. | Pelgrim CE et al. | β | 2017 | β |
| Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease. | Daulatzai MA | β | 2017 | β |
| Charlson Comorbidity Index, inappropriate medication use and cognitive impairment : Bermuda Triangle. | Silay K et al. | β | 2017 | β |
| Comprehensive effects of galantamine and cilostazol combination therapy on patients with Alzheimer's disease with asymptomatic lacunar infarction. | Hishikawa N et al. | β | 2017 | β |
| Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort study. | Schilling S et al. | β | 2017 | β |
| Differential effects of voluntary treadmill exercise and caloric restriction on tau pathogenesis in a mouse model of Alzheimer's disease-like tau pathology fed with Western diet. | Gratuze M et al. | β | 2017 | β |
| DNA methylation alterations in Alzheimer's disease. | Yokoyama AS et al. | β | 2017 | β |
| Does medial temporal lobe thickness mediate the association between risk factor burden and memory performance in middle-aged or older adults with metabolic syndrome? | McIntosh EC et al. | β | 2017 | β |
| Effect of a Long-Term Intensive Lifestyle Intervention on Cognitive Function: Action for Health in Diabetes Study. | Rapp SR et al. | β | 2017 | β |
| Effect of pomegranate extracts on brain antioxidant markers and cholinesterase activity in high fat-high fructose diet induced obesity in rat model. | Amri Z et al. | β | 2017 | β |
| Effect of Vascular Risk Factors on the Progression of Mild Alzheimer's Disease and Lewy Body Dementia. | Bergland AK et al. | β | 2017 | β |
| Effects of Tooth Loss and the Apolipoprotein E Ι4 Allele on Mild Memory Impairment in the Fujiwara-kyo Study of Japan: A Nested Case-Control Study. | Okamoto N et al. | β | 2017 | β |
| Evaluation of Amyloid Protective Factors and Alzheimer Disease Neurodegeneration Protective Factors in Elderly Individuals. | Vemuri P et al. | β | 2017 | β |
| Executive function in weight loss and weight loss maintenance: a conceptual review and novel neuropsychological model of weight control. | Gettens KM et al. | β | 2017 | β |
| Factors related to continuous and discontinuous attendance at memory clinics. | Hishikawa N et al. | β | 2017 | β |
| Ghrelin, Amylin, Gastric Inhibitory Peptide and Cognition in Middle-Aged HIV-Infected and Uninfected Women: The Women's Interagency HIV Study. | McFarlane SI et al. | β | 2017 | β |
| Global loss of acetylcholinesterase activity with mitochondrial complexes inhibition and inflammation in brain of hypercholesterolemic mice. | Paul R et al. | β | 2017 | β |
| Higher body mass index is associated with reduced posterior default mode connectivity in older adults. | Beyer F et al. | β | 2017 | β |
| Hypercholesterolaemia and vascular dementia. | Appleton JP et al. | β | 2017 | β |
| Hyperinsulinemia and elevated systolic blood pressure independently predict white matter hyperintensities with associated cognitive decrement in the middle-aged offspring of dementia patients. | Hawkins KA et al. | β | 2017 | β |
| Hypertension, diabetes and obesity are associated with lower cognitive performance in community-dwelling elderly: Data from the FIBRA study. | de Oliveira MFB et al. | β | 2017 | β |
| Insulin resistance is associated with lower arterial blood flow and reduced cortical perfusion in cognitively asymptomatic middle-aged adults. | Hoscheidt SM et al. | β | 2017 | β |
| Late-Life Body Mass Index, Rapid Weight Loss, Apolipoprotein E Ξ΅4 and the Risk of Cognitive Decline and Incident Dementia. | Bell SP et al. | β | 2017 | β |
| Less is more: Caloric regulation of neurogenesis and adult brain function. | Morgan AH et al. | β | 2017 | β |
| Midlife Metabolic Profile and the Risk of Late-Life Cognitive Decline. | Tortelli R et al. | β | 2017 | β |
| Modeling the Relationships Among Late-Life Body Mass Index, Cerebrovascular Disease, and Alzheimer's Disease Neuropathology in an Autopsy Sample of 1,421 Subjects from the National Alzheimer's Coordinating Center Data Set. | Alosco ML et al. | β | 2017 | β |
| Molecular genetics of human obesity: A comprehensive review. | Singh RK et al. | β | 2017 | β |
| Nutrition research in cognitive impairment/dementia, with a focus on soya and folate. | Hogervorst E et al. | β | 2017 | β |
| Obesity and brain illness: from cognitive and psychological evidences to obesity paradox. | Monda V et al. | β | 2017 | β |
| Prevalence and incidence of Alzheimer's disease in Europe: A meta-analysis. | Niu H et al. | β | 2017 | β |
| Reduced neurotrophic factor level is the early event before the functional neuronal deficiency in high-fat diet induced obese mice. | Wang H et al. | β | 2017 | β |
| Relationship between anthropometric parameters and open angle glaucoma: The Korea National Health and Nutrition Examination Survey. | Lee JY et al. | β | 2017 | β |
| Screening for mild cognitive impairment in patients with cardiovascular risk factors. | Yaneva-Sirakova T et al. | β | 2017 | β |
| Serum high-density lipoprotein is associated with better cognitive function in a cross-sectional study of aging women. | Bates KA et al. | β | 2017 | β |
| Sleep and cognitive aging: emerging bedfellows: Editorial for Carvalho etΒ al. | Keage HAD | β | 2017 | β |
| Ten Challenges of the Amyloid Hypothesis of Alzheimer's Disease. | Kepp KP | β | 2017 | β |
| The Alkamide <i>trans</i>-Pellitorine Targets PPARΞ³ via TRPV1 and TRPA1 to Reduce Lipid Accumulation in Developing 3T3-L1 Adipocytes. | Lieder B et al. | β | 2017 | β |
| The Effect of Number of Teeth and Chewing Ability on Cognitive Function of Elderly in UAE: A Pilot Study. | Seraj Z et al. | β | 2017 | β |
| The frequency and influence of dementia risk factors in prodromal Alzheimer's disease. | Bos I et al. | β | 2017 | β |
| United States Indigenous Populations and Dementia: Is There a Case for Culture-based Psychosocial Interventions? | Browne CV et al. | β | 2017 | β |
| Update on Alzheimer's Disease Therapy and Prevention Strategies. | Graham WV et al. | β | 2017 | β |
| Visual-Constructional Ability in Individuals with Severe Obesity: Rey Complex Figure Test Accuracy and the Q-Score. | SargΓ©nius HL et al. | β | 2017 | β |
| 'Adipaging': ageing and obesity share biological hallmarks related to a dysfunctional adipose tissue. | PΓ©rez LM et al. | β | 2016 | β |
| Adipocyte-derived factors in age-related dementia and their contribution to vascular and Alzheimer pathology. | Ishii M et al. | β | 2016 | β |
| Aging and adipose tissue: potential interventions for diabetes and regenerative medicine. | Palmer AK et al. | β | 2016 | β |
| Amylin-mediated control of glycemia, energy balance, and cognition. | Mietlicki-Baase EG | β | 2016 | β |
| Amyloid-beta immunotherapy: the hope for Alzheimer disease? | Barrera-Ocampo A et al. | β | 2016 | β |
| Are Chronic Periodontitis and Gingivitis Associated with Dementia? A Nationwide, Retrospective, Matched-Cohort Study in Taiwan. | Tzeng NS et al. | β | 2016 | β |
| Body Mass Index Predicts Progression of Mild Cognitive Impairment to Dementia. | Cova I et al. | β | 2016 | β |
| Chronic consumption of a western diet induces robust glial activation in aging mice and in a mouse model of Alzheimer's disease. | Graham LC et al. | β | 2016 | β |
| Cognitive Impairment Among the Aging Population in a Community in Southwest Nigeria. | Adebiyi AO et al. | β | 2016 | β |
| Cortisol, HDL-c, VLDL-c, and APOE Polymorphisms as Laboratorial Parameters Associated to Cognitive Impairment No Dementia (CIND) and Dementia. | Lara VP et al. | β | 2016 | β |
| Decline in Weight and Incident Mild Cognitive Impairment: Mayo Clinic Study of Aging. | Alhurani RE et al. | β | 2016 | β |
| Dementias. | Sacuiu SF | β | 2016 | β |
| Detrimental effects of a high fat/high cholesterol diet on memory and hippocampal markers in aged rats. | Ledreux A et al. | β | 2016 | β |
| Diet and Inflammation in Alzheimer's Disease and Related Chronic Diseases: A Review. | Gardener SL et al. | β | 2016 | β |
| Drug-induced cognitive impairment: Effect of cardiovascular agents. | Marvanova M | β | 2016 | β |
| Effects of Exercise on Cognition: The Finnish Alzheimer Disease Exercise Trial: A Randomized, Controlled Trial. | Γhman H et al. | β | 2016 | β |
| Effects of vascular risk factors, statins, and antihypertensive drugs on PiB deposition in cognitively normal subjects. | Glodzik L et al. | β | 2016 | β |
| Examining if being overweight really confers protection against dementia: Sixty-four year follow-up of participants in the Glasgow University alumni cohort study. | Batty GD et al. | β | 2016 | β |
| From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways. | Rogers GB et al. | β | 2016 | β |
| From Heart Health to Brain Health: Legacy of the North Karelia Project for Dementia Research. | Kivipelto M et al. | β | 2016 | β |
| Higher body mass index in older adults is associated with lower gray matter volume: implications for memory performance. | Kharabian Masouleh S et al. | β | 2016 | β |
| High-fat, high-sugar, and high-cholesterol consumption does not impact tau pathogenesis in a mouse model of Alzheimer's disease-like tau pathology. | Gratuze M et al. | β | 2016 | β |
| Impact of obstructive sleep apnea syndrome on cognition in early postmenopausal women. | Lal C et al. | β | 2016 | β |
| Is the Mediterranean diet a feasible approach to preserving cognitive function and reducing risk of dementia for older adults in Western countries? New insights and future directions. | Knight A et al. | β | 2016 | β |
| Low Hemoglobin Levels and the Onset of Cognitive Impairment in Older People: The PRO.V.A. Study. | Trevisan C et al. | β | 2016 | β |
| Neuroprotective effects of sodium hydrosulfide against Ξ²-amyloid-induced neurotoxicity. | Li XH et al. | β | 2016 | β |
| Nutritional Status is Associated with Faster Cognitive Decline and Worse Functional Impairment in the Progression of Dementia: The Cache County Dementia Progression Study1. | Sanders C et al. | β | 2016 | β |
| Obesity and Structural Brain Integrity in Older Women: The Women's Health Initiative Magnetic Resonance Imaging Study. | Driscoll I et al. | β | 2016 | β |
| Predictive Factors for Verbal Memory Performance Over Decades of Aging: Data from the Women's Healthy Ageing Project. | Szoeke C et al. | β | 2016 | β |
| Predictors of Long-Term Change in Adult Cognitive Performance: Systematic Review and Data from the Northern Finland Birth Cohort 1966. | Rannikko I et al. | β | 2016 | β |
| Reconstituted high-density lipoproteins acutely reduce soluble brain AΞ² levels in symptomatic APP/PS1 mice. | Robert J et al. | β | 2016 | β |
| Role of metabolism in neurodegenerative disorders. | Procaccini C et al. | β | 2016 | β |
| Serum high-molecular-weight adiponectin level and incident dementia in patients with vascular risk factors. | Kitagawa K et al. | β | 2016 | β |
| Statins for the prevention of dementia. | McGuinness B et al. | β | 2016 | β |
| Sugar-sweetened soft drinks are associated with poorer cognitive function in individuals with type 2 diabetes: the Maine-Syracuse Longitudinal Study. | Crichton GE et al. | β | 2016 | β |
| The effect of Sailuotong (SLT) on neurocognitive and cardiovascular function in healthy adults: a randomised, double-blind, placebo controlled crossover pilot trial. | Steiner GZ et al. | β | 2016 | β |
| The risk of overweight/obesity in mid-life and late life for the development of dementia: a systematic review and meta-analysis of longitudinal studies. | Pedditzi E et al. | β | 2016 | β |
| The therapeutic potential of metabolic hormones in the treatment of age-related cognitive decline and Alzheimer's disease. | Grizzanti J et al. | β | 2016 | β |
| Treatment strategies in Alzheimer's disease: a review with focus on selenium supplementation. | Aaseth J et al. | β | 2016 | β |
| Unstable Body Mass Index and Progression to Probable Alzheimer's Disease Dementia in Patients with Amnestic Mild Cognitive Impairment. | Ye BS et al. | β | 2016 | β |
| 37 Years of Body Mass Index and Dementia: Effect Modification by the APOE Genotype: Observations from the Prospective Population Study of Women in Gothenburg, Sweden. | BΓ€ckman K et al. | β | 2015 | β |
| Advances in the prevention of Alzheimer's Disease. | Sindi S et al. | β | 2015 | β |
| Age and Vascular Burden Determinants of Cortical Hemodynamics Underlying Verbal Fluency. | Heinzel S et al. | β | 2015 | β |
| Alzheimer disease prevention: New optimism. | Filley CM | β | 2015 | β |
| Apolipoprotein E Ξ΅-4 as a genetic determinant of Alzheimer's disease heterogeneity. | Kotze MJ et al. | β | 2015 | β |
| ASK1 is involved in cognitive impairment caused by long-term high-fat diet feeding in mice. | Toyama K et al. | β | 2015 | β |
| Association between insulin resistance and cognition in patients with depressive disorders: exploratory analyses into age-specific effects. | Wroolie TE et al. | β | 2015 | β |
| Bioimpedance vector analysis and conventional bioimpedance to assess body composition in older adults with dementia. | Camina MartΓn MA et al. | β | 2015 | β |
| BMI and risk of dementia in two million people over two decades: a retrospective cohort study. | Qizilbash N et al. | β | 2015 | β |
| Cellular and metabolic alterations in the hippocampus caused by insulin signalling dysfunction and its association with cognitive impairment during aging and Alzheimer's disease: studies in animal models. | Calvo-Ochoa E et al. | β | 2015 | β |
| Cholesterol, statins, and dementia: what the cardiologist should know. | Wanamaker BL et al. | β | 2015 | β |
| Correlates of Incident Cognitive Impairment in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. | Gillett SR et al. | β | 2015 | β |
| Diversity and plasticity of microglial cells in psychiatric and neurological disorders. | Nakagawa Y et al. | β | 2015 | β |
| Endoplasmic reticulum stress impairs insulin receptor signaling in the brains of obese rats. | Liang L et al. | β | 2015 | β |
| Heart failure and Alzheimer's disease. | Cermakova P et al. | β | 2015 | β |
| High-fat diet-induced deregulation of hippocampal insulin signaling and mitochondrial homeostasis deficiences contribute to Alzheimer disease pathology in rodents. | Petrov D et al. | β | 2015 | β |
| Hypnotics use but not insomnia increased the risk of dementia in traumatic brain injury patients. | Chiu HY et al. | β | 2015 | β |
| Low cardiac index is associated with incident dementia and Alzheimer disease: the Framingham Heart Study. | Jefferson AL et al. | β | 2015 | β |
| Menopause, obesity and inflammation: interactive risk factors for Alzheimer's disease. | Christensen A et al. | β | 2015 | β |
| Metformin treatment alters memory function in a mouse model of Alzheimer's disease. | DiTacchio KA et al. | β | 2015 | β |
| Mild cognitive impairment risk factor survey of the Xinjiang Uyghur and Han elderly. | Keyimu K et al. | β | 2015 | β |
| Multidomain Lifestyle Interventions for the Prevention of Cognitive Decline After Ischemic Stroke: Randomized Trial. | Matz K et al. | β | 2015 | β |
| Nationwide Inpatient Prevalence, Predictors, and Outcomes of Alzheimer's Disease among Older Adults in the United States, 2002-2012. | Beydoun MA et al. | β | 2015 | β |
| New perspectives on schizophrenia in later life: implications for treatment, policy, and research. | Cohen CI et al. | β | 2015 | β |
| Nonivamide enhances miRNA let-7d expression and decreases adipogenesis PPARΞ³ expression in 3T3-L1 cells. | Rohm B et al. | β | 2015 | β |
| Obesity and Aging: Consequences for Cognition, Brain Structure, and Brain Function. | Bischof GN et al. | β | 2015 | β |
| Overweight and Obesity in Midlife and Brain Structure and Dementia 26 Years Later: The AGES-Reykjavik Study. | Albanese E et al. | β | 2015 | β |
| Paths to Alzheimer's disease prevention: from modifiable risk factors to biomarker enrichment strategies. | Lista S et al. | β | 2015 | β |
| Pre-operative history of depression and cognitive changes in bariatric surgery patients. | Alosco ML et al. | β | 2015 | β |
| Prevention of poststroke cognitive decline: ASPIS--a multicenter, randomized, observer-blind, parallel group clinical trial to evaluate multiple lifestyle interventions--study design and baseline characteristics. | Brainin M et al. | β | 2015 | β |
| Projecting Burden of Dementia in Spain, 2010-2050: Impact of Modifying Risk Factors. | Soto-Gordoa M et al. | β | 2015 | β |
| Protective effect of Daming capsule against chronic cerebral ischemia. | Song X et al. | β | 2015 | β |
| Relationship between cognitive impairment and echocardiographic parameters: a review. | Arangalage D et al. | β | 2015 | β |
| Sex hormone binding globulin and verbal memory in older men. | Takayanagi Y et al. | β | 2015 | β |
| Shared Neuropathological Characteristics of Obesity, Type 2 Diabetes and Alzheimer's Disease: Impacts on Cognitive Decline. | Walker JM et al. | β | 2015 | β |
| Stability in Cognitive Function Over 18 Years: Prevalence and Predictors among Older Mexican Americans. | Howrey BT et al. | β | 2015 | β |
| Surgical and Nonsurgical Interventions for Obesity in Service of Preserving Cognitive Function. | Haley AP et al. | β | 2015 | β |
| The orexigenic hormone acyl-ghrelin increases adult hippocampal neurogenesis and enhances pattern separation. | Kent BA et al. | β | 2015 | β |
| Voluntary cognitive screening: characteristics of participants in an Asian setting. | Ho V et al. | β | 2015 | β |
| 2014 Alzheimer's disease facts and figures. | Alzheimer's Association | β | 2014 | β |
| Abdominal obesity and lower gray matter volume: a Mendelian randomization study. | Debette S et al. | β | 2014 | β |
| ABO blood type, factor VIII, and incident cognitive impairment in the REGARDS cohort. | Alexander KS et al. | β | 2014 | β |
| Adipokines: a link between obesity and dementia? | Kiliaan AJ et al. | β | 2014 | β |
| Aging exacerbates obesity-induced cerebromicrovascular rarefaction, neurovascular uncoupling, and cognitive decline in mice. | Tucsek Z et al. | β | 2014 | β |
| An association study between epicardial fat thickness and cognitive impairment in the elderly. | Mazzoccoli G et al. | β | 2014 | β |
| A neurodegenerative vascular burden index and the impact on cognition. | Heinzel S et al. | β | 2014 | β |
| Aspartic acid in the hippocampus: a biomarker for postoperative cognitive dysfunction. | Hu R et al. | β | 2014 | β |
| Association between binge eating disorder and changes in cognitive functioning following bariatric surgery. | Lavender JM et al. | β | 2014 | β |
| Atherosclerosis, biomarkers of atherosclerosis and Alzheimer's disease. | Fiolaki A et al. | β | 2014 | β |
| Before it is too late: professional responsibilities in late-onset Alzheimer's research and pre-symptomatic prediction. | Schicktanz S et al. | β | 2014 | β |
| Blood markers of fatty acids and vitamin D, cardiovascular measures, body mass index, and physical activity relate to longitudinal cortical thinning in normal aging. | Walhovd KB et al. | β | 2014 | β |
| Body mass index and biliary tract disease: a systematic review and meta-analysis of prospective studies. | Park M et al. | β | 2014 | β |
| Body-mass index and mortality in incident dementia: a cohort study on 11,398 patients from SveDem, the Swedish Dementia Registry. | GarcΓa-Ptacek S et al. | β | 2014 | β |
| Body mass index in dementia. | GarcΓa-Ptacek S et al. | β | 2014 | β |
| Body Mass Index in Different Dementia Disorders: Results from the Swedish Dementia Quality Registry (SveDem). | FaxΓ©n-Irving G et al. | β | 2014 | β |
| Cardiovascular medication burden in dementia disorders: a nationwide study of 19,743 dementia patients in the Swedish Dementia Registry. | Cermakova P et al. | β | 2014 | β |
| Change in body mass index before and after Alzheimer's disease onset. | Gu Y et al. | β | 2014 | β |
| Cholesterol in mild cognitive impairment and Alzheimer's disease in a birth cohort over 14 years. | Toro P et al. | β | 2014 | β |
| Cognitive decline, dietary factors and gut-brain interactions. | Caracciolo B et al. | β | 2014 | β |
| Cognitive function after bariatric surgery: evidence for improvement 3 years after surgery. | Alosco ML et al. | β | 2014 | β |
| Cognitive memory screening and referral program in community pharmacies in the United States. | Rickles NM et al. | β | 2014 | β |
| DASH and Mediterranean-type Dietary Patterns to Maintain Cognitive Health. | Tangney CC | β | 2014 | β |
| Dementia and cognitive impairment: epidemiology, diagnosis, and treatment. | Hugo J et al. | β | 2014 | β |
| Diet-induced obesity and low testosterone increase neuroinflammation and impair neural function. | Jayaraman A et al. | β | 2014 | β |
| Different susceptibility of medial temporal lobe and basal ganglia atrophy rates to vascular risk factors. | de Jong LW et al. | β | 2014 | β |
| Dynamic changes of Apo A1 mediated by LXR/RXR/ABCA1 pathway in brains of the aging rats with cerebral hypoperfusion. | Wang L et al. | β | 2014 | β |
| Effect of meditation on cognitive functions in context of aging and neurodegenerative diseases. | Marciniak R et al. | β | 2014 | β |
| Effect of physical exercise on cognitive performance in older adults with mild cognitive impairment or dementia: a systematic review. | Γhman H et al. | β | 2014 | β |
| Effect of weight loss, exercise, or both on cognition and quality of life in obese older adults. | Napoli N et al. | β | 2014 | β |
| Effects of diet-induced obesity and voluntary exercise in a tauopathy mouse model: implications of persistent hyperleptinemia and enhanced astrocytic leptin receptor expression. | Koga S et al. | β | 2014 | β |
| Estrogen: a master regulator of bioenergetic systems in the brain and body. | Rettberg JR et al. | β | 2014 | β |
| Future directions in Alzheimer's disease from risk factors to prevention. | Imtiaz B et al. | β | 2014 | β |
| High-density lipoproteins and cerebrovascular integrity in Alzheimer's disease. | Stukas S et al. | β | 2014 | β |
| High-fat diet-induced memory impairment in triple-transgenic Alzheimer's disease (3xTgAD) mice isΒ independent of changes in amyloid and tau pathology. | Knight EM et al. | β | 2014 | β |
| High-Fat-Diet-Induced Weight Gain Ameliorates Bone Loss without Exacerbating AΞ²PP Processing and Cognition in Female APP/PS1 Mice. | Peng Y et al. | β | 2014 | β |
| Hypercholesterolemia induces short-term spatial memory impairments in mice: up-regulation of acetylcholinesterase activity as an early and causal event? | Moreira EL et al. | β | 2014 | β |
| Impact of a multi-nutrient diet on cognition, brain metabolism, hemodynamics, and plasticity in apoE4 carrier and apoE knockout mice. | Jansen D et al. | β | 2014 | β |
| Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease. | De Felice FG et al. | β | 2014 | β |
| Is Alzheimer's disease related to metabolic syndrome? A Wnt signaling conundrum. | RΓos JA et al. | β | 2014 | β |
| Long-term amelioration of telmisartan on metabolic syndrome-related molecules in stroke-resistant spontaneously hypertensive rat after transient middle cerebral artery occlusion. | Deguchi K et al. | β | 2014 | β |
| Modifiable risk factors for Alzheimer disease and subjective memory impairment across age groups. | Chen ST et al. | β | 2014 | β |
| Multifactorial vascular risk factor intervention to prevent cognitive impairment after stroke and TIA: a 12-month randomized controlled trial. | Ihle-Hansen H et al. | β | 2014 | β |
| Neurocognitive functioning in overweight and obese patients with bipolar disorder: data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM). | Silveira LE et al. | β | 2014 | β |
| Neuroprotective effects of leptin in the context of obesity and metabolic disorders. | Davis C et al. | β | 2014 | β |
| Neuropsychology in Multidisciplinary Stroke Care: Clinical Feasibility of the NINDS-CSN Vascular Cognitive Impairment Harmonization Standards. | Han DY et al. | β | 2014 | β |
| Obesity and dementia: adipokines interact with the brain. | Arnoldussen IA et al. | β | 2014 | β |
| Obesity and neuroinflammation: a pathway to cognitive impairment. | Miller AA et al. | β | 2014 | β |
| Obesity: pathophysiology and intervention. | Zhang Y et al. | β | 2014 | β |
| Physical activity and cognitive function in bariatric surgery candidates. | Galioto R et al. | β | 2014 | β |
| Physical activity, inflammation, and volume of the aging brain. | Braskie MN et al. | β | 2014 | β |
| Physical exercise and cognitive performance in the elderly: current perspectives. | Kirk-Sanchez NJ et al. | β | 2014 | β |
| Racial/ethnic variations in the relation between body mass index and cognitive function among older adults. | Bryant AN et al. | β | 2014 | β |
| Relation of DASH- and Mediterranean-like dietary patterns to cognitive decline in older persons. | Tangney CC et al. | β | 2014 | β |
| Self-reported physical activity is associated with cognitive function in lean, but not obese individuals. | Galioto Wiedemann R et al. | β | 2014 | β |
| Short-term high-fat-and-fructose feeding produces insulin signaling alterations accompanied by neurite and synaptic reduction and astroglial activation in the rat hippocampus. | Calvo-Ochoa E et al. | β | 2014 | β |
| The effects of obesity on the cerebral vasculature. | Dorrance AM et al. | β | 2014 | β |
| The metabolic syndrome and cognitive decline in the Atherosclerosis Risk in Communities study (ARIC). | Dearborn JL et al. | β | 2014 | β |
| TOR-dependent cerebrovascular aging in Alzheimer's disease. | Jahrling JB et al. | β | 2014 | β |
| Total cholesterol and neuropsychiatric symptoms in Alzheimer's disease: the impact of total cholesterol level and gender. | Hall JR et al. | β | 2014 | β |
| 2013 Alzheimer's disease facts and figures. | Alzheimer's Association | β | 2013 | β |
| A conceptual framework and ethics analysis for prevention trials of Alzheimer Disease. | Peters KR et al. | β | 2013 | β |
| Adiposity and cognitive decline in the cardiovascular health study. | Luchsinger JA et al. | β | 2013 | β |
| Anthropometric indices and dietary intake: prospective determinants of geriatric cognitive impairment? | Agarwal A et al. | β | 2013 | β |
| Anthropometric measures and cognition in middle-aged HIV-infected and uninfected women. The Women's Interagency HIV Study. | Gustafson DR et al. | β | 2013 | β |
| Association between northern Manhattan study global vascular risk score and successful aging. | Warsch JR et al. | β | 2013 | β |
| Body mass index and neurocognitive functioning across the adult lifespan. | Stanek KM et al. | β | 2013 | β |
| Body mass index, lifestyles, physical performance and cognitive decline: the "Treviso Longeva (TRELONG)" study. | Gallucci M et al. | β | 2013 | β |
| Body weight variability in midlife and risk for dementia in old age. | Ravona-Springer R et al. | β | 2013 | β |
| B-type natriuretic peptide and severity of cognitive disorder. | Hiltunen M et al. | β | 2013 | β |
| Can bariatric surgery reduce risk of Alzheimer's disease? | Stanek KM et al. | β | 2013 | β |
| Cerebrovascular reactivity to carbon dioxide in Alzheimer's disease. | Glodzik L et al. | β | 2013 | β |
| Change in body fat mass is independently associated with executive functions in older women: a secondary analysis of a 12-month randomized controlled trial. | Dao E et al. | β | 2013 | β |
| Cognitive health begins at conception: addressing dementia as a lifelong and preventable condition. | Barnett JH et al. | β | 2013 | β |
| Critical window hypothesis of hormone therapy and cognition: a scientific update on clinical studies. | Maki PM | β | 2013 | β |
| Cross-sectional study examining the association between metabolic syndrome and cognitive function among the oldest old. | Luo L et al. | β | 2013 | β |
| Curcumin induces ABCA1 expression and apolipoprotein A-I-mediated cholesterol transmembrane in the chronic cerebral hypoperfusion aging rats. | Tian M et al. | β | 2013 | β |
| Detrimental effects of diet-induced obesity on Ο pathology are independent of insulin resistance in Ο transgenic mice. | Leboucher A et al. | β | 2013 | β |
| Does obesity-induced Ο phosphorylation tip the scale toward dementia? | Gendron TF et al. | β | 2013 | β |
| Dyslipidemia and the risk of Alzheimer's disease. | Reitz C | β | 2013 | β |
| Dyslipidemia links obesity to early cerebral neurochemical alterations. | Haley AP et al. | β | 2013 | β |
| Heart disease as a risk factor for dementia. | Justin BN et al. | β | 2013 | β |
| High adiposity: risk factor for dementia and Alzheimer's disease? | Gustafson DR et al. | β | 2013 | β |
| Hunger in the absence of caloric restriction improves cognition and attenuates Alzheimer's disease pathology in a mouse model. | Dhurandhar EJ et al. | β | 2013 | β |
| Insulin, cognition, and dementia. | Cholerton B et al. | β | 2013 | β |
| Is obesity a brain disease? | Shefer G et al. | β | 2013 | β |
| Late-life obesity is associated with smaller global and regional gray matter volumes: a voxel-based morphometric study. | Brooks SJ et al. | β | 2013 | β |
| LDL phenotype in subjects with mild cognitive impairment and Alzheimer's disease. | Vikarunnessa S et al. | β | 2013 | β |
| Leptin regulates amyloid Ξ² production via the Ξ³-secretase complex. | Niedowicz DM et al. | β | 2013 | β |
| Midlife cardiovascular risk factors and late cognitive impairment. | Virta JJ et al. | β | 2013 | β |
| Midlife obesity and dementia: meta-analysis and adjusted forecast of dementia prevalence in the United States and China. | Loef M et al. | β | 2013 | β |
| Midlife stroke risk and cognitive decline: a 10-year follow-up of the Whitehall II cohort study. | Kaffashian S et al. | β | 2013 | β |
| Midlife vascular risk factors and their association with dementia deaths: results from a Norwegian prospective study followed up for 35 years. | Strand BH et al. | β | 2013 | β |
| Neurotoxic saboteurs: straws that break the hippo's (hippocampus) back drive cognitive impairment and Alzheimer's Disease. | Daulatzai MA | β | 2013 | β |
| Normal aging and cognition: the unacknowledged contribution of cerebrovascular risk factors. | Morra L et al. | β | 2013 | β |
| Nutrition and neurodegeneration: epidemiological evidence and challenges for future research. | Gillette-Guyonnet S et al. | β | 2013 | β |
| Nutrition and the risk of Alzheimer's disease. | Hu N et al. | β | 2013 | β |
| Obesity and impaired cognitive functioning in the elderly: a population-based cross-sectional study (NEDICES). | Benito-LeΓ³n J et al. | β | 2013 | β |
| Obesity and mental illness: implications for cognitive functioning. | McIntyre RS et al. | β | 2013 | β |
| Predicting cognitive decline: a dementia risk score vs. the Framingham vascular risk scores. | Kaffashian S et al. | β | 2013 | β |
| Progress towards a consensus on biomarkers for Alzheimer's disease: a review of peripheral analytes. | Rembach A et al. | β | 2013 | β |
| Prolonged diet induced obesity has minimal effects towards brain pathology in mouse model of cerebral amyloid angiopathy: implications for studying obesity-brain interactions in mice. | Zhang L et al. | β | 2013 | β |
| Renin-angiotensin-aldosterone system has a pivotal role in cognitive impairment. | Yagi S et al. | β | 2013 | β |
| Rivastigmine for vascular cognitive impairment. | Birks J et al. | β | 2013 | β |
| Sex Differences in Presynaptic Density and Neurogenesis in Middle-Aged ApoE4 and ApoE Knockout Mice. | Rijpma A et al. | β | 2013 | β |
| Sex-specific effects of high fat diet on indices of metabolic syndrome in 3xTg-AD mice: implications for Alzheimer's disease. | Barron AM et al. | β | 2013 | β |
| The emerging role of dietary fructose in obesity and cognitive decline. | Lakhan SE et al. | β | 2013 | β |
| The paradox of overnutrition in aging and cognition. | Fielding RA et al. | β | 2013 | β |
| Vascular risk factors and cognitive disorders. | Debette S | β | 2013 | β |
| White matter alteration in metabolic syndrome: diffusion tensor analysis. | Shimoji K et al. | β | 2013 | β |
| 2012 Alzheimer's disease facts and figures. | Alzheimer's Association | β | 2012 | β |
| Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play. | Jack CR | β | 2012 | β |
| Alzheimer's disease: a clinical practice-oriented review. | Alves L et al. | β | 2012 | β |
| Amyloid precursor protein and proinflammatory changes are regulated in brain and adipose tissue in a murine model of high fat diet-induced obesity. | Puig KL et al. | β | 2012 | β |
| A prospective examination of the relationship between physical activity and dementia risk in later life. | Bowen ME | β | 2012 | β |
| Body composition and military performance--many things to many people. | Friedl KE | β | 2012 | β |
| Body mass index and the risk of dementia among Louisiana low income diabetic patients. | Hu G et al. | β | 2012 | β |
| Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease. | Ewers M et al. | β | 2012 | β |
| Central obesity in the elderly is related to late-onset Alzheimer disease. | Luchsinger JA et al. | β | 2012 | β |
| Cholesteryl Ester Transfer Protein (CETP) genotype and cognitive function in persons aged 35 years or older. | Izaks GJ et al. | β | 2012 | β |
| Dementia prevention: current epidemiological evidence and future perspective. | Mangialasche F et al. | β | 2012 | β |
| Does physical activity reduce risk for Alzheimer's disease through interaction with the stress neuroendocrine system? | Tortosa-MartΓnez J et al. | β | 2012 | β |
| Dysfunctional nucleus tractus solitarius: its crucial role in promoting neuropathogenetic cascade of Alzheimer's dementia--a novel hypothesis. | Daulatzai MA | β | 2012 | β |
| Dyslipidemia and dementia: current epidemiology, genetic evidence, and mechanisms behind the associations. | Reitz C | β | 2012 | β |
| Epidemiological of and risk factors for Alzheimer's disease: a review. | Povova J et al. | β | 2012 | β |
| Epidemiology of Alzheimer disease. | Mayeux R et al. | β | 2012 | β |
| Exercise is more effective than diet control in preventing high fat diet-induced Ξ²-amyloid deposition and memory deficit in amyloid precursor protein transgenic mice. | Maesako M et al. | β | 2012 | β |
| Genetic variants in the Fat and Obesity Associated (FTO) gene and risk of Alzheimer's disease. | Reitz C et al. | β | 2012 | β |
| Geographical variation in dementia: systematic review with meta-analysis. | Russ TC et al. | β | 2012 | β |
| Hypermetabolism in a triple-transgenic mouse model of Alzheimer's disease. | Knight EM et al. | β | 2012 | β |
| [Is it possible to reduce health inequalities in old age?]. | Michel JP et al. | β | 2012 | β |
| Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders. | Cai H et al. | β | 2012 | β |
| Midlife obesity and trajectories of brain volume changes in older adults. | Driscoll I et al. | β | 2012 | β |
| Mild cognitive impairment is associated with selected functional markers: integrating concurrent, longitudinal, and stability effects. | Dolcos S et al. | β | 2012 | β |
| Neuroimaging and obesity: current knowledge and future directions. | Carnell S et al. | β | 2012 | β |
| No association between gain in body mass index across the life course and midlife cognitive function and cognitive reserve--the 1946 British Birth Cohort study. | Albanese E et al. | β | 2012 | β |
| Novel imaging strategies for assessment of cerebrovascular involvement. | Tang CY et al. | β | 2012 | β |
| Obesity and psychotic disorders: uncovering common mechanisms through metabolomics. | Oresic M | β | 2012 | β |
| Quintessential risk factors: their role in promoting cognitive dysfunction and Alzheimer's disease. | Daulatzai MA | β | 2012 | β |
| Sterol lipid metabolism in down syndrome revisited: down syndrome is associated with a selective reduction in serum brassicasterol levels. | Tansley G et al. | β | 2012 | β |
| The effects of meditation on perceived stress and related indices of psychological status and sympathetic activation in persons with Alzheimer's disease and their caregivers: a pilot study. | Innes KE et al. | β | 2012 | β |
| The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE. | Guerreiro RJ et al. | β | 2012 | β |
| The LXR agonist GW3965 increases apoA-I protein levels in the central nervous system independent of ABCA1. | Stukas S et al. | β | 2012 | β |
| The relationship between visceral adiposity and cognitive performance in older adults. | Yoon DH et al. | β | 2012 | β |
| The Role of Insulin and Insulin-Like Growth Factor-1/FoxO-Mediated Transcription for the Pathogenesis of Obesity-Associated Dementia. | Moll L et al. | β | 2012 | β |
| Vascular risk factors in Alzheimer's disease - preliminary report. | Stefanova E et al. | β | 2012 | β |
| 2011 Alzheimer's disease facts and figures. | Alzheimer's Association | β | 2011 | β |
| Accelerated weight loss and incident dementia in an elderly African-American cohort. | Gao S et al. | β | 2011 | β |
| A longitudinal study of gray matter volume decline with age and modifying factors. | Taki Y et al. | β | 2011 | β |
| Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimer's disease. | Biron KE et al. | β | 2011 | β |
| Antihypertensive therapy is associated with reduced rate of conversion to Alzheimer's disease in midregional proatrial natriuretic peptide stratified subjects with mild cognitive impairment. | Schneider P et al. | β | 2011 | β |
| A review of the association between obesity and cognitive function across the lifespan: implications for novel approaches to prevention and treatment. | Smith E et al. | β | 2011 | β |
| Association between metabolic syndrome and cognitive decline: a systematic review of prospective population-based studies. | Hao Z et al. | β | 2011 | β |
| Atlas-derived perfusion correlates of white matter hyperintensities in patients with reduced cardiac output. | Jefferson AL et al. | β | 2011 | β |
| A transdisciplinary perspective of chronic stress in relation to psychopathology throughout life span development. | Juster RP et al. | β | 2011 | β |
| Body adiposity in later life and the incidence of dementia: the health in men study. | Power BD et al. | β | 2011 | β |
| Can stroke cause neurodegenerative dementia? | Cumming TB et al. | β | 2011 | β |
| Changes in vascular risk factors from midlife to late life and white matter lesions: a 20-year follow-up study. | Vuorinen M et al. | β | 2011 | β |
| Comprehension of complex instructions deteriorates with age and vascular morbidity. | Sakellaridou E et al. | β | 2011 | β |
| Dementia: five new things. | Filley CM et al. | β | 2011 | β |
| Diabetes mellitus and Alzheimer's disease: shared pathology and treatment? | Akter K et al. | β | 2011 | β |
| Dietary omega 3 polyunsaturated fatty acids and Alzheimer's disease: interaction with apolipoprotein E genotype. | Barberger-Gateau P et al. | β | 2011 | β |
| Effects of socially stimulating group intervention on lonely, older people's cognition: a randomized, controlled trial. | Pitkala KH et al. | β | 2011 | β |
| For debate: substituting placebo controls in long-term Alzheimer's prevention trials. | Spiegel R et al. | β | 2011 | β |
| Higher education delays and shortens cognitive impairment: a multistate life table analysis of the US Health and Retirement Study. | Reuser M et al. | β | 2011 | β |
| Insulin resistance and pathological brain ageing. | Cholerton B et al. | β | 2011 | β |
| Intelligence in youth and all-cause-mortality: systematic review with meta-analysis. | Calvin CM et al. | β | 2011 | β |
| Interaction between body mass index and central adiposity and risk of incident cognitive impairment and dementia: results from the Women's Health Initiative Memory Study. | Kerwin DR et al. | β | 2011 | β |
| Intracranial atherosclerosis as a contributing factor to Alzheimer's disease dementia. | Roher AE et al. | β | 2011 | β |
| Latest Advances on Interventions that May Prevent, Delay or Ameliorate Dementia. | Wilson D et al. | β | 2011 | β |
| Metabolic syndrome exacerbates short-term postoperative cognitive dysfunction in patients undergoing cardiac surgery: results of a pilot study. | Hudetz JA et al. | β | 2011 | β |
| Midlife overweight and obesity increase late-life dementia risk: a population-based twin study. | Xu WL et al. | β | 2011 | β |
| Obesity, leptin, and Alzheimer's disease. | Lee EB | β | 2011 | β |
| Other dementias. | Krumina G | β | 2011 | β |
| Postoperative cognitive dysfunction after noncardiac surgery: effects of metabolic syndrome. | Hudetz JA et al. | β | 2011 | β |
| Predictive utility of the Framingham general cardiovascular disease risk profile for cognitive function: evidence from the Whitehall II study. | Kaffashian S et al. | β | 2011 | β |
| Risk factors and preventive interventions for Alzheimer disease: state of the science. | Daviglus ML et al. | β | 2011 | β |
| The complex interplay of cardiovascular system and cognition: how to predict dementia in the elderly? | Kerola T et al. | β | 2011 | β |
| The fat mass and obesity gene is linked to reduced verbal fluency in overweight and obese elderly men. | Benedict C et al. | β | 2011 | β |
| The relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairment. | Gold AB et al. | β | 2011 | β |
| The Relationship between Metabolic Syndrome and Cognitive Function. | Oh HM et al. | β | 2011 | β |
| Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. | Gorelick PB et al. | β | 2011 | β |
| Vascular risk factors and longitudinal changes on brain MRI: the ARIC study. | Knopman DS et al. | β | 2011 | β |
| Weight change and cognitive function: findings from the Women's Health Initiative Study of Cognitive Aging. | Driscoll I et al. | β | 2011 | β |
| Weight loss and incident dementia in elderly Yoruba Nigerians: a 10-year follow-up study. | Ogunniyi A et al. | β | 2011 | β |
| 2010 Alzheimer's disease facts and figures. | Alzheimer's Association | β | 2010 | β |
| Adiposity hormones and dementia. | Gustafson DR | β | 2010 | β |
| Adiposity predicts cognitive decline in older persons with diabetes: a 2-year follow-up. | Abbatecola AM et al. | β | 2010 | β |
| Advances and perspectives from genetic research: development of biological markers in Alzheimer's disease. | Zetzsche T et al. | β | 2010 | β |
| Apolipoprotein A-I deficiency increases cerebral amyloid angiopathy and cognitive deficits in APP/PS1DeltaE9 mice. | Lefterov I et al. | β | 2010 | β |
| Being overweight in midlife is associated with lower cognitive ability and steeper cognitive decline in late life. | Dahl A et al. | β | 2010 | β |
| Brain aging: lessons from community studies. | Fratiglioni L et al. | β | 2010 | β |
| B-type natriuretic peptide as a predictor of declining cognitive function and dementia--a cohort study of an elderly general population with a 5-year follow-up. | Kerola T et al. | β | 2010 | β |
| Can statins prevent dementia in older adults? | Haan MN | β | 2010 | β |
| Cardiac output as a potential risk factor for abnormal brain aging. | Jefferson AL | β | 2010 | β |
| [Course modifying therapy of Alzheimer's dementia]. | Heneka MT | β | 2010 | β |
| Diabetes, related conditions, and dementia. | Luchsinger JA | β | 2010 | β |
| Education and physical activity mediate the relationship between ethnicity and cognitive function in late middle-aged adults. | Masel MC et al. | β | 2010 | β |
| Effects of the dietary approaches to stop hypertension diet, exercise, and caloric restriction on neurocognition in overweight adults with high blood pressure. | Smith PJ et al. | β | 2010 | β |
| Elevated cerebral glutamate and myo-inositol levels in cognitively normal middle-aged adults with metabolic syndrome. | Haley AP et al. | β | 2010 | β |
| Encephalopathies: the emerging diabetic complications. | Sima AA | β | 2010 | β |
| Gene-environment interaction research and transgenic mouse models of Alzheimer's disease. | Chouliaras L et al. | β | 2010 | β |
| Hypertension and dementia. | Nagai M et al. | β | 2010 | β |
| [Life-course approach to cognitive ageing]. | Sabia S et al. | β | 2010 | β |
| Liver X receptor agonist treatment ameliorates amyloid pathology and memory deficits caused by high-fat diet in APP23 mice. | Fitz NF et al. | β | 2010 | β |
| Longitudinal examination of obesity and cognitive function: results from the Baltimore longitudinal study of aging. | Gunstad J et al. | β | 2010 | β |
| [Longitudinal studies on aging: past, present and future]. | Inzitari M | β | 2010 | β |
| Longitudinal trajectories of cognitive decline among older adults with cardiovascular disease. | Okonkwo OC et al. | β | 2010 | β |
| Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders. | Profenno LA et al. | β | 2010 | β |
| Metabolic abnormalities in adult and geriatric major depression with and without comorbid dementia. | Blank K et al. | β | 2010 | β |
| Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease. | Frisardi V et al. | β | 2010 | β |
| Obesity is linked with lower brain volume in 700 AD and MCI patients. | Ho AJ et al. | β | 2010 | β |
| Obesity, smoking, and frontal brain dysfunction. | Bauer L et al. | β | 2010 | β |
| Overweight in midlife is related to lower cognitive function 30 years later: a prospective study with longitudinal assessments. | Hassing LB et al. | β | 2010 | β |
| Plasma Pentraxin 3, but not high-sensitivity C-reactive protein, is a useful inflammatory biomarker for predicting cognitive impairment in elderly hypertensive patients. | Yano Y et al. | β | 2010 | β |
| Predictors of performance on the MMSE and the DRS-2 among American Indian elders. | Jervis LL et al. | β | 2010 | β |
| Prevalence and neurodegenerative or other associations with olfactory impairment in an older community. | Karpa MJ et al. | β | 2010 | β |
| Structural brain differences and cognitive functioning related to body mass index in older females. | Walther K et al. | β | 2010 | β |
| Systematic review of health behavioral risks and cognitive health in older adults. | Lee Y et al. | β | 2010 | β |
| The cross-sectional relationship between body mass index, waist-hip ratio, and cognitive performance in postmenopausal women enrolled in the Women's Health Initiative. | Kerwin DR et al. | β | 2010 | β |
| The effect of midlife physical activity on structural brain changes in the elderly. | Rovio S et al. | β | 2010 | β |
| The effects of hypertension and body mass index on cognition in schizophrenia. | Friedman JI et al. | β | 2010 | β |
| The relationship between inflammatory markers and post stroke cognitive impairment. | Rothenburg LS et al. | β | 2010 | β |
| Type 2 diabetes mellitus, dyslipidemia, and Alzheimer's disease. | Carlsson CM | β | 2010 | β |
| Using nature and outdoor activity to improve children's health. | McCurdy LE et al. | β | 2010 | β |
| Vascular health risks and fMRI activation during a memory task in older adults. | Braskie MN et al. | β | 2010 | β |
| Vascular risk factor detection and control may prevent Alzheimer's disease. | de la Torre JC | β | 2010 | β |
| [Vascular risk factors and cognitive performance in patients 50 to 65 years-old]. | Miralbell J et al. | β | 2010 | β |
| Vascular risk factors: imaging and neuropathologic correlates. | Knopman DS et al. | β | 2010 | β |
| Visceral fat is associated with lower brain volume in healthy middle-aged adults. | Debette S et al. | β | 2010 | β |
| Will testing for apolipoprotein E assist in tailoring dementia risk reduction? A review. | Low LF et al. | β | 2010 | β |
| Adiposity and Alzheimer's disease. | Luchsinger JA et al. | β | 2009 | β |
| Adiposity indicators and dementia over 32 years in Sweden. | Gustafson DR et al. | β | 2009 | β |
| Adiposity parameters and cognitive function in the elderly: application of "Jolly Fat" hypothesis to cognition. | Han C et al. | β | 2009 | β |
| Adiposity, type 2 diabetes, and Alzheimer's disease. | Luchsinger JA et al. | β | 2009 | β |
| Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age. | Kok E et al. | β | 2009 | β |
| Association between mid-life marital status and cognitive function in later life: population based cohort study. | HΓ₯kansson K et al. | β | 2009 | β |
| Blood pressure and the risk for dementia: a double edged sword. | Kennelly SP et al. | β | 2009 | β |
| Body adiposity in late life and risk of dementia or cognitive impairment in a longitudinal community-based study. | West NA et al. | β | 2009 | β |
| Body mass index over the adult life course and cognition in late midlife: the Whitehall II Cohort Study. | Sabia S et al. | β | 2009 | β |
| Cardiovascular and biochemical risk factors for incident dementia in the Hypertension in the Very Elderly Trial. | Peters R et al. | β | 2009 | β |
| Cardiovascular risk factors and dementia mortality: 40 years of follow-up in the Seven Countries Study. | Alonso A et al. | β | 2009 | β |
| Cardiovascular risk factors and incident Alzheimer disease: a systematic review of the literature. | Purnell C et al. | β | 2009 | β |
| Cerebral emboli in the genesis of dementia. | Purandare N et al. | β | 2009 | β |
| Changing perspectives regarding late-life dementia. | Fotuhi M et al. | β | 2009 | β |
| Chinese herbal medicine Yi-Gan-San decreases the lipid accumulation in mouse 3T3-L1 adipocytes by modulating the activities of transcription factors SREBP-1c and FoxO1. | Izumi M et al. | β | 2009 | β |
| Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention. | Qiu C et al. | β | 2009 | β |
| Mental slowness and executive dysfunctions in patients with metabolic syndrome. | Segura B et al. | β | 2009 | β |
| Midlife and late-life obesity and the risk of dementia: cardiovascular health study. | Fitzpatrick AL et al. | β | 2009 | β |
| Modifiable Midlife Risk Factors for Late-Life Cognitive Impairment and Dementia. | Hughes TF et al. | β | 2009 | β |
| Obesity: What is an elderly population growing into? | Salihu HM et al. | β | 2009 | β |
| Overweight in midlife and risk of dementia: a 40-year follow-up study. | Hassing LB et al. | β | 2009 | β |
| Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence. | Hamer M et al. | β | 2009 | β |
| Postmenopausal hormone therapy and subclinical cerebrovascular disease: the WHIMS-MRI Study. | Coker LH et al. | β | 2009 | β |
| Prevalence of dementia in mountainous village of Sicily. | Spada RS et al. | β | 2009 | β |
| Prevention of dementia by intensive vascular care (PreDIVA): a cluster-randomized trial in progress. | Richard E et al. | β | 2009 | β |
| Psychological considerations for bariatric surgery among older adults. | Henrickson HC et al. | β | 2009 | β |
| Risk of dementia hospitalisation associated with cardiovascular risk factors in midlife and older age: the Atherosclerosis Risk in Communities (ARIC) study. | Alonso A et al. | β | 2009 | β |
| The influence of age on the association between cholesterol and cognitive function. | van Vliet P et al. | β | 2009 | β |
| The metabolic syndrome and development of cognitive impairment among older women. | Yaffe K et al. | β | 2009 | β |
| The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. | Maalouf M et al. | β | 2009 | β |
| The prevention of dementia. | Peters R | β | 2009 | β |
| Therapeutic potential of lipase inhibitor orlistat in Alzheimer's disease. | Du J et al. | β | 2009 | β |
| Total and regional adiposity and cognitive change in older adults: The Health, Aging and Body Composition (ABC) study. | Kanaya AM et al. | β | 2009 | β |
| Treatment of vascular risk factors is associated with slower decline in Alzheimer disease. | Deschaintre Y et al. | β | 2009 | β |
| Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognition. | van den Berg E et al. | β | 2009 | β |
| [Vascular risk factors and Alzheimer's disease]. | Regalado DoΓ±a PJ et al. | β | 2009 | β |
| Vascular risk factors and cognitive functions in nondemented elderly individuals. | Wiederkehr S et al. | β | 2009 | β |
| Vascular risk factors and dementia revisited. | Debette S et al. | β | 2009 | β |
| Weighty concerns: the growing prevalence of obesity among older adults. | Houston DK et al. | β | 2009 | β |
| A comparison of cardiovascular disease risk factor biomarkers in African Americans and Yoruba Nigerians. | Deeg M et al. | β | 2008 | β |
| Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective. | Luchsinger JA | β | 2008 | β |
| A life course of adiposity and dementia. | Gustafson D | β | 2008 | β |
| Alzheimer's disease - the ways of prevention. | Kivipelto M et al. | β | 2008 | β |
| Amyloid precursor protein expression is upregulated in adipocytes in obesity. | Lee YH et al. | β | 2008 | β |
| Aspirin in Alzheimer's disease (AD2000): a randomised open-label trial. | AD2000 Collaborative Group et al. | β | 2008 | β |
| Association of adiposity status and changes in early to mid-adulthood with incidence of Alzheimer's disease. | Beydoun MA et al. | β | 2008 | β |
| Association of body mass index with cognitive function in elderly hypertensive Japanese. | Sakakura K et al. | β | 2008 | β |
| Body mass index and cognitive decline in a biracial community population. | Sturman MT et al. | β | 2008 | β |
| Body mass index and magnetic resonance markers of brain integrity in adults. | Gazdzinski S et al. | β | 2008 | β |
| Cardiovascular risk factors and dementia. | Fillit H et al. | β | 2008 | β |
| Central obesity and increased risk of dementia more than three decades later. | Whitmer RA et al. | β | 2008 | β |
| Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review. | Kloppenborg RP et al. | β | 2008 | β |
| Diabetes and overweight associate with non-APOE4 genotype in an Alzheimer's disease population. | Profenno LA et al. | β | 2008 | β |
| Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment. | Poon IO | β | 2008 | β |
| Fatty acids, lipid metabolism and Alzheimer pathology. | Hooijmans CR et al. | β | 2008 | β |
| Growing old with epilepsy: the neglected issue of cognitive and brain health in aging and elder persons with chronic epilepsy. | Hermann B et al. | β | 2008 | β |
| Late-life body mass index and dementia incidence: nine-year follow-up data from the Kungsholmen Project. | Atti AR et al. | β | 2008 | β |
| Neuropsychological contributions to the early identification of Alzheimer's disease. | Bondi MW et al. | β | 2008 | β |
| Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis. | Beydoun MA et al. | β | 2008 | β |
| Relationship between body mass index and gray matter volume in 1,428 healthy individuals. | Taki Y et al. | β | 2008 | β |
| Risk factors for dementia in the epidemiological study of Munguialde County (Basque Country-Spain). | FernΓ‘ndez MartΓnez M et al. | β | 2008 | β |
| Risk-reducing effect of education in Alzheimer's disease. | Sando SB et al. | β | 2008 | β |
| Role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the action of ginsenoside Rh2 against beta-amyloid-induced inhibition of rat brain astrocytes. | Shieh PC et al. | β | 2008 | β |
| The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics. | Jones RW et al. | β | 2008 | β |
| The worldwide challenge of the dementias: a role for B vitamins and homocysteine? | Smith AD | β | 2008 | β |
| Weight loss as a predictor of dementia and Alzheimer's disease? | NourhashΓ©mi F et al. | β | 2008 | β |
| When being thin is not a virtue. | Knopman DS | β | 2008 | β |
| A Dietary supplement containing standardized Phaseolus vulgaris extract influences body composition of overweight men and women. | Celleno L et al. | β | 2007 | β |
| Adiposity and Alzheimer's disease. | Luchsinger JA et al. | β | 2007 | β |
| Dietary patterns and risk of dementia: the Three-City cohort study. | Barberger-Gateau P et al. | β | 2007 | β |
| Education and dementia: what lies behind the association? | Ngandu T et al. | β | 2007 | β |
| Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide. | Krewski D et al. | β | 2007 | β |
| Incident dementia in women is preceded by weight loss by at least a decade. | Knopman DS et al. | β | 2007 | β |
| Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease. | Halagappa VK et al. | β | 2007 | β |
| Invited commentary: lipoproteins and dementia - is it the apolipoprotein A-I? | Scarmeas N | β | 2007 | β |
| Less atherosclerosis and lower blood pressure for a meaningful life perspective with more brain. | Staessen JA et al. | β | 2007 | β |
| Measures of adiposity and dementia risk in elderly persons. | Luchsinger JA et al. | β | 2007 | β |
| Mid-life adiposity factors relate to blood-brain barrier integrity in late life. | Gustafson DR et al. | β | 2007 | β |
| Midlife risk factors for subtypes of dementia: a nested case-control study in Taiwan. | Chiang CJ et al. | β | 2007 | β |
| Obesity in women: a life cycle of medical risk. | Ryan D | β | 2007 | β |
| Prevention of Alzheimer's disease. | Szekely CA et al. | β | 2007 | β |
| [Risk factors and protective factors of the insanities]. | ClΓ©ment JP | β | 2007 | β |
| Somatotype in Alzheimer's disease. | Buffa R et al. | β | 2007 | β |
| The elephant in the room - healthy brains in later life, epidemiology and public health. | Brayne C | β | 2007 | β |
| The epidemiology of the dementias: an update. | Qiu C et al. | β | 2007 | β |
| The prevention of the dementia epidemic. | Korczyn AD et al. | β | 2007 | β |
| Adiposity indices and dementia. | Gustafson D | β | 2006 | β |
| Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease. | Martins IJ et al. | β | 2006 | β |
| Association of metabolic syndrome with Alzheimer disease: a population-based study. | Vanhanen M et al. | β | 2006 | β |
| Can we prevent, delay, or shorten the course of dementia? | Van Gool WA | β | 2006 | β |
| Cerebral embolism and Alzheimer's disease. | Kivipelto M et al. | β | 2006 | β |
| Cholesterol as a risk factor for Alzheimer's disease - epidemiological evidence. | Kivipelto M et al. | β | 2006 | β |
| Commentary on "Vascular cognitive impairment: today and tomorrow." Vascular cognitive impairment: yesterday, today, and tomorrow. | Hachinski V | β | 2006 | β |
| Interventions for heart disease and their effects on Alzheimer's disease. | Wolozin B et al. | β | 2006 | β |
| National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. | Hachinski V et al. | β | 2006 | β |
| Obesity, abdominal obesity and Alzheimer disease. | Razay G et al. | β | 2006 | β |
| Of mice and men: more neurobiology in dementia. | Codita A et al. | β | 2006 | β |
| Organ systems dependent on nitric oxide and the potential for nitric oxide-targeted therapies in related diseases. | Hollenberg NK | β | 2006 | β |
| Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. | Kivipelto M et al. | β | 2006 | β |
| Roles of cholesterol and lipids in the etiopathogenesis of Alzheimer's disease. | Rojo L et al. | β | 2006 | β |
| Therapy Insight: type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease. | Haan MN | β | 2006 | β |
| Treatment of dementia: anything new? | Machado JC et al. | β | 2006 | β |
| Update on hypertension and Alzheimer's disease. | Skoog I et al. | β | 2006 | β |